MXPA99003921A - Cleansing products - Google Patents
Cleansing productsInfo
- Publication number
- MXPA99003921A MXPA99003921A MXPA/A/1999/003921A MX9903921A MXPA99003921A MX PA99003921 A MXPA99003921 A MX PA99003921A MX 9903921 A MX9903921 A MX 9903921A MX PA99003921 A MXPA99003921 A MX PA99003921A
- Authority
- MX
- Mexico
- Prior art keywords
- oil
- further characterized
- product
- water
- cleaning
- Prior art date
Links
- 230000003750 conditioning Effects 0.000 claims abstract description 124
- 239000000758 substrate Substances 0.000 claims abstract description 115
- 239000004094 surface-active agent Substances 0.000 claims abstract description 99
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 84
- 210000003491 Skin Anatomy 0.000 claims abstract description 80
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 64
- 210000004209 Hair Anatomy 0.000 claims abstract description 60
- 238000004519 manufacturing process Methods 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims description 103
- 238000004140 cleaning Methods 0.000 claims description 75
- -1 polypropylenes Polymers 0.000 claims description 73
- 238000005187 foaming Methods 0.000 claims description 72
- 239000000463 material Substances 0.000 claims description 50
- 239000004480 active ingredient Substances 0.000 claims description 40
- 239000000835 fiber Substances 0.000 claims description 34
- 125000000217 alkyl group Chemical group 0.000 claims description 29
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 27
- 239000000194 fatty acid Substances 0.000 claims description 27
- 229940083542 Sodium Drugs 0.000 claims description 22
- 150000004665 fatty acids Chemical class 0.000 claims description 22
- 239000011734 sodium Substances 0.000 claims description 22
- 229910052708 sodium Inorganic materials 0.000 claims description 22
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 claims description 21
- 239000005720 sucrose Substances 0.000 claims description 21
- 229920000728 polyester Polymers 0.000 claims description 20
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 20
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 16
- 229920000297 Rayon Polymers 0.000 claims description 14
- 239000003921 oil Substances 0.000 claims description 14
- 235000019198 oils Nutrition 0.000 claims description 14
- 239000002964 rayon Substances 0.000 claims description 14
- 239000000516 sunscreening agent Substances 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 12
- 150000002430 hydrocarbons Chemical class 0.000 claims description 11
- 125000000129 anionic group Chemical group 0.000 claims description 10
- 238000000151 deposition Methods 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 230000000475 sunscreen Effects 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- GHMLBKRAJCXXBS-UHFFFAOYSA-N Resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 claims description 8
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 8
- 239000008103 glucose Substances 0.000 claims description 8
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 7
- OAAZUWWNSYWWHG-UHFFFAOYSA-N 1-phenoxypropan-1-ol Chemical compound CCC(O)OC1=CC=CC=C1 OAAZUWWNSYWWHG-UHFFFAOYSA-N 0.000 claims description 6
- 229940063953 AMMONIUM LAURYL SULFATE Drugs 0.000 claims description 6
- BTBJBAZGXNKLQC-UHFFFAOYSA-N Ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 claims description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 6
- 238000007648 laser printing Methods 0.000 claims description 6
- 235000019271 petrolatum Nutrition 0.000 claims description 6
- 235000021317 phosphate Nutrition 0.000 claims description 6
- 238000005507 spraying Methods 0.000 claims description 6
- 239000008158 vegetable oil Substances 0.000 claims description 6
- 239000004342 Benzoyl peroxide Substances 0.000 claims description 5
- 229920000742 Cotton Polymers 0.000 claims description 5
- OMPJBNCRMGITSC-UHFFFAOYSA-N Incidol Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims description 5
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims description 5
- 239000004264 Petrolatum Substances 0.000 claims description 5
- 229940066842 Petrolatum Drugs 0.000 claims description 5
- 229960005323 Phenoxyethanol Drugs 0.000 claims description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N Phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 5
- 239000004743 Polypropylene Substances 0.000 claims description 5
- 150000001412 amines Chemical class 0.000 claims description 5
- 229960003328 benzoyl peroxide Drugs 0.000 claims description 5
- 235000019400 benzoyl peroxide Nutrition 0.000 claims description 5
- 238000007598 dipping method Methods 0.000 claims description 5
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 5
- 235000019136 lipoic acid Nutrition 0.000 claims description 5
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims description 5
- 229920001155 polypropylene Polymers 0.000 claims description 5
- 229960002663 thioctic acid Drugs 0.000 claims description 5
- 229940079881 Disodium Lauroamphodiacetate Drugs 0.000 claims description 4
- 229950002499 Fytic acid Drugs 0.000 claims description 4
- 240000006962 Gossypium hirsutum Species 0.000 claims description 4
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 4
- SYELZBGXAIXKHU-UHFFFAOYSA-N Lauryldimethylamine oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 claims description 4
- CMWTZPSULFXXJA-VIFPVBQESA-N Naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims description 4
- 229940068041 Phytic Acid Drugs 0.000 claims description 4
- 239000004952 Polyamide Substances 0.000 claims description 4
- SHGAZHPCJJPHSC-YCNIQYBTSA-N Retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 4
- 229960001727 Tretinoin Drugs 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 4
- 230000000845 anti-microbial Effects 0.000 claims description 4
- 229940071160 cocoate Drugs 0.000 claims description 4
- ZPRZNBBBOYYGJI-UHFFFAOYSA-L disodium;2-[1-[2-(carboxylatomethoxy)ethyl]-2-undecyl-4,5-dihydroimidazol-1-ium-1-yl]acetate;hydroxide Chemical compound [OH-].[Na+].[Na+].CCCCCCCCCCCC1=NCC[N+]1(CCOCC([O-])=O)CC([O-])=O ZPRZNBBBOYYGJI-UHFFFAOYSA-L 0.000 claims description 4
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- SUMDYPCJJOFFON-UHFFFAOYSA-M isethionate Chemical class OCCS([O-])(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-M 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 229960002009 naproxen Drugs 0.000 claims description 4
- 235000002949 phytic acid Nutrition 0.000 claims description 4
- 239000000467 phytic acid Substances 0.000 claims description 4
- 229920002647 polyamide Polymers 0.000 claims description 4
- 229920000098 polyolefin Polymers 0.000 claims description 4
- 229960003471 retinol Drugs 0.000 claims description 4
- 239000011607 retinol Substances 0.000 claims description 4
- 235000020944 retinol Nutrition 0.000 claims description 4
- 229960004889 salicylic acid Drugs 0.000 claims description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N trans-Retinyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims description 4
- IBLKWZIFZMJLFL-UHFFFAOYSA-N 1-phenoxypropan-2-ol Chemical compound CC(O)COC1=CC=CC=C1 IBLKWZIFZMJLFL-UHFFFAOYSA-N 0.000 claims description 3
- ZQBJRVYLUFBBEQ-UHFFFAOYSA-N 2-[diamino(3-formamidopropyl)azaniumyl]acetate Chemical compound [O-]C(=O)C[N+](N)(N)CCCNC=O ZQBJRVYLUFBBEQ-UHFFFAOYSA-N 0.000 claims description 3
- BDJRBEYXGGNYIS-UHFFFAOYSA-N Azelaic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 claims description 3
- 229920003043 Cellulose fiber Polymers 0.000 claims description 3
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 claims description 3
- 102000011782 Keratins Human genes 0.000 claims description 3
- 108010076876 Keratins Proteins 0.000 claims description 3
- 229940048866 LAURAMINE OXIDE Drugs 0.000 claims description 3
- 229940053487 Niacinamide Drugs 0.000 claims description 3
- DXGLGDHPHMLXJC-UHFFFAOYSA-N Oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 claims description 3
- 229940106026 PHENOXYISOPROPANOL Drugs 0.000 claims description 3
- 206010069250 Product deposit Diseases 0.000 claims description 3
- 229940048106 SODIUM LAUROYL ISETHIONATE Drugs 0.000 claims description 3
- GCSPRLPXTPMSTL-IBDNADADSA-N [(2S,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GCSPRLPXTPMSTL-IBDNADADSA-N 0.000 claims description 3
- 229940098323 ammonium cocoyl isethionate Drugs 0.000 claims description 3
- 230000003255 anti-acne Effects 0.000 claims description 3
- 230000000843 anti-fungal Effects 0.000 claims description 3
- 230000003110 anti-inflammatory Effects 0.000 claims description 3
- OPVLOHUACNWTQT-UHFFFAOYSA-N azane;2-dodecoxyethyl hydrogen sulfate Chemical compound N.CCCCCCCCCCCCOCCOS(O)(=O)=O OPVLOHUACNWTQT-UHFFFAOYSA-N 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000002480 mineral oil Substances 0.000 claims description 3
- 235000010446 mineral oil Nutrition 0.000 claims description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 3
- 239000011570 nicotinamide Substances 0.000 claims description 3
- 229960003966 nicotinamide Drugs 0.000 claims description 3
- 235000005152 nicotinamide Nutrition 0.000 claims description 3
- 229960001173 oxybenzone Drugs 0.000 claims description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 3
- BRMSVEGRHOZCAM-UHFFFAOYSA-M sodium;2-dodecanoyloxyethanesulfonate Chemical compound [Na+].CCCCCCCCCCCC(=O)OCCS([O-])(=O)=O BRMSVEGRHOZCAM-UHFFFAOYSA-M 0.000 claims description 3
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims description 3
- 240000000218 Cannabis sativa Species 0.000 claims description 2
- 240000000491 Corchorus aestuans Species 0.000 claims description 2
- 235000011777 Corchorus aestuans Nutrition 0.000 claims description 2
- 235000010862 Corchorus capsularis Nutrition 0.000 claims description 2
- 229920000727 Decyl polyglucose Polymers 0.000 claims description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N Dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 claims description 2
- 229940120503 Dihydroxyacetone Drugs 0.000 claims description 2
- 229920002821 Modacrylic Polymers 0.000 claims description 2
- 239000004698 Polyethylene (PE) Substances 0.000 claims description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M Sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims description 2
- ICUTUKXCWQYESQ-UHFFFAOYSA-N Triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 claims description 2
- 150000001242 acetic acid derivatives Chemical class 0.000 claims description 2
- 230000000111 anti-oxidant Effects 0.000 claims description 2
- 230000001153 anti-wrinkle Effects 0.000 claims description 2
- 239000004599 antimicrobial Substances 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 235000006708 antioxidants Nutrition 0.000 claims description 2
- 235000009120 camo Nutrition 0.000 claims description 2
- 235000005607 chanvre indien Nutrition 0.000 claims description 2
- 239000012459 cleaning agent Substances 0.000 claims description 2
- 239000011487 hemp Substances 0.000 claims description 2
- 235000012765 hemp Nutrition 0.000 claims description 2
- 239000003589 local anesthetic agent Substances 0.000 claims description 2
- 235000012766 marijuana Nutrition 0.000 claims description 2
- 229920001778 nylon Polymers 0.000 claims description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229920005862 polyol Polymers 0.000 claims description 2
- 150000003077 polyols Chemical class 0.000 claims description 2
- 229920002689 polyvinyl acetate Polymers 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 229940108325 retinyl palmitate Drugs 0.000 claims description 2
- 235000019172 retinyl palmitate Nutrition 0.000 claims description 2
- 239000011769 retinyl palmitate Substances 0.000 claims description 2
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 claims description 2
- 230000003637 steroidlike Effects 0.000 claims description 2
- 150000003445 sucroses Chemical class 0.000 claims description 2
- 229950004578 vitamin A palmitate Drugs 0.000 claims description 2
- HGMITUYOCPPQLE-UHFFFAOYSA-N 3-Quinuclidinyl benzilate Chemical compound C1N(CC2)CCC2C1OC(=O)C(O)(C=1C=CC=CC=1)C1=CC=CC=C1 HGMITUYOCPPQLE-UHFFFAOYSA-N 0.000 claims 1
- XIOBZUDJYKXUEL-UHFFFAOYSA-N 4-ethyl-2-[(4-methoxyphenyl)methylidene]octanoic acid Chemical compound CCCCC(CC)CC(C(O)=O)=CC1=CC=C(OC)C=C1 XIOBZUDJYKXUEL-UHFFFAOYSA-N 0.000 claims 1
- 239000004166 Lanolin Substances 0.000 claims 1
- 229940039717 Lanolin Drugs 0.000 claims 1
- 229920001131 Pulp (paper) Polymers 0.000 claims 1
- SNQJGRGLKWHREQ-UHFFFAOYSA-M Sodium lauroamphoacetate Chemical compound [Na+].CCCCCCCCCCCC1=NCC[N]1(CCO)CC([O-])=O SNQJGRGLKWHREQ-UHFFFAOYSA-M 0.000 claims 1
- 229940091252 Sodium supplements Drugs 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 1
- 229940121375 antifungals Drugs 0.000 claims 1
- OCSIXPGPUXCISD-UHFFFAOYSA-N azane;2-[dodecanoyl(methyl)amino]acetic acid Chemical compound N.CCCCCCCCCCCC(=O)N(C)CC(O)=O OCSIXPGPUXCISD-UHFFFAOYSA-N 0.000 claims 1
- 235000010980 cellulose Nutrition 0.000 claims 1
- 229920000831 ionic polymer Polymers 0.000 claims 1
- 235000019388 lanolin Nutrition 0.000 claims 1
- 229920002635 polyurethane Polymers 0.000 claims 1
- 239000004814 polyurethane Substances 0.000 claims 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims 1
- 229920002545 silicone oil Polymers 0.000 claims 1
- 229940079776 sodium cocoyl isethionate Drugs 0.000 claims 1
- 229940057950 sodium laureth sulfate Drugs 0.000 claims 1
- 238000009736 wetting Methods 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 86
- 239000004615 ingredient Substances 0.000 description 52
- 125000004432 carbon atoms Chemical group C* 0.000 description 35
- 150000001735 carboxylic acids Chemical class 0.000 description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 14
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 13
- 235000000346 sugar Nutrition 0.000 description 12
- 150000002148 esters Chemical class 0.000 description 11
- 239000010410 layer Substances 0.000 description 11
- 239000006260 foam Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 10
- 150000001298 alcohols Chemical class 0.000 description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- DUFKCOQISQKSAV-UHFFFAOYSA-N 2-(2-hydroxypropoxy)propan-1-ol Chemical compound CC(O)COC(C)CO DUFKCOQISQKSAV-UHFFFAOYSA-N 0.000 description 8
- 125000003342 alkenyl group Chemical group 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000000654 additive Substances 0.000 description 7
- 125000005466 alkylenyl group Chemical group 0.000 description 7
- 239000003093 cationic surfactant Substances 0.000 description 7
- 239000003995 emulsifying agent Substances 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 7
- BJHIKXHVCXFQLS-UYFOZJQFSA-N Fructose Natural products OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 229920001451 Polypropylene glycol Polymers 0.000 description 6
- 239000002280 amphoteric surfactant Substances 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000003549 soybean oil Substances 0.000 description 6
- 235000012424 soybean oil Nutrition 0.000 description 6
- 239000003760 tallow Substances 0.000 description 6
- 230000000996 additive Effects 0.000 description 5
- 239000003945 anionic surfactant Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 238000009834 vaporization Methods 0.000 description 5
- 240000007170 Cocos nucifera Species 0.000 description 4
- 235000013162 Cocos nucifera Nutrition 0.000 description 4
- GZCGUPFRVQAUEE-KCDKBNATSA-N D-(+)-Galactose Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- GUBGYTABKSRVRQ-YOLKTULGSA-N Maltose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@H]1CO)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 GUBGYTABKSRVRQ-YOLKTULGSA-N 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 235000019482 Palm oil Nutrition 0.000 description 4
- OFVLGDICTFRJMM-WESIUVDSSA-N Tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 4
- 229960002180 Tetracycline Drugs 0.000 description 4
- 239000004098 Tetracycline Substances 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-M bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- 239000008406 cosmetic ingredient Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drugs Drugs 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000000670 limiting Effects 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- 239000002540 palm oil Substances 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 229920002994 synthetic fiber Polymers 0.000 description 4
- 235000019364 tetracycline Nutrition 0.000 description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N α-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N 1-[(1S,2R,3R,4S,5R,6R)-3-carbamimidamido-6-{[(2R,3R,4R,5S)-3-{[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 3
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- BTSZTGGZJQFALU-UHFFFAOYSA-N Piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 3
- 206010040844 Skin exfoliation Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 239000003212 astringent agent Substances 0.000 description 3
- 125000004429 atoms Chemical group 0.000 description 3
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 3
- 229940116224 behenate Drugs 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N butylene glycol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-M carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 3
- 150000001733 carboxylic acid esters Chemical class 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- BYMMIQCVDHHYGG-UHFFFAOYSA-J chloride;phosphate Chemical compound [Cl-].[O-]P([O-])([O-])=O BYMMIQCVDHHYGG-UHFFFAOYSA-J 0.000 description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L disodium;2-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 3
- 229960003276 erythromycin Drugs 0.000 description 3
- 238000004299 exfoliation Methods 0.000 description 3
- 239000004088 foaming agent Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229960000890 hydrocortisone Drugs 0.000 description 3
- 229960001680 ibuprofen Drugs 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229940021182 non-steroidal anti-inflammatory drugs Drugs 0.000 description 3
- 229950001046 piroctone Drugs 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- WSEBKJRVPMLGFV-UHFFFAOYSA-M (3-chloro-2-hydroxypropyl)-(2-hydroxyethyl)-dimethylazanium;chloride Chemical compound [Cl-].OCC[N+](C)(C)CC(O)CCl WSEBKJRVPMLGFV-UHFFFAOYSA-M 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- AKKAHKUMGLHDSH-UHFFFAOYSA-O 2,3-dihydroxypropyl-dimethyl-[3-(octadecanoylamino)propyl]azanium Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CO AKKAHKUMGLHDSH-UHFFFAOYSA-O 0.000 description 2
- IJFXRHURBJZNAO-UHFFFAOYSA-N 3-Hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1 IJFXRHURBJZNAO-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-Hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229920002972 Acrylic fiber Polymers 0.000 description 2
- 244000144927 Aloe barbadensis Species 0.000 description 2
- 235000002961 Aloe barbadensis Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- 229920004511 Dow Corning® 200 Fluid Polymers 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 238000004566 IR spectroscopy Methods 0.000 description 2
- 229960000448 Lactic acid Drugs 0.000 description 2
- OYHQOLUKZRVURQ-UHFFFAOYSA-N Linoleic acid Chemical compound CCCCCC=CCC=CCCCCCCCC(O)=O OYHQOLUKZRVURQ-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 2
- 125000003047 N-acetyl group Chemical group 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- 101710008755 PPP1R15A Proteins 0.000 description 2
- XDRYMKDFEDOLFX-UHFFFAOYSA-N Pentamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 XDRYMKDFEDOLFX-UHFFFAOYSA-N 0.000 description 2
- 229960004448 Pentamidine Drugs 0.000 description 2
- 229920005830 Polyurethane Foam Polymers 0.000 description 2
- 235000019774 Rice Bran oil Nutrition 0.000 description 2
- 229940079862 Sodium Lauryl Sarcosinate Drugs 0.000 description 2
- YYGNTYWPHWGJRM-RUSDCZJESA-N Squalene Natural products C(=C\CC/C(=C\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\C)/C)/C YYGNTYWPHWGJRM-RUSDCZJESA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229960003080 Taurine Drugs 0.000 description 2
- NLVFBUXFDBBNBW-PBSUHMDJSA-N Tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-SQOUGZDYSA-N Xylose Natural products O[C@@H]1CO[C@@H](O)[C@@H](O)[C@@H]1O SRBFZHDQGSBBOR-SQOUGZDYSA-N 0.000 description 2
- 229940046282 Zinc Drugs 0.000 description 2
- 229940091251 Zinc Supplements Drugs 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 125000002877 alkyl aryl group Chemical group 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 125000005418 aryl aryl group Chemical group 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 229960004022 clotrimazole Drugs 0.000 description 2
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 2
- ZPUCINDJVBIVPJ-BARDWOONSA-N cocaine Natural products O([C@@H]1C[C@H]2CC[C@H](N2C)[C@@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-BARDWOONSA-N 0.000 description 2
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000000875 corresponding Effects 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- LVXUNJWLKCUTNF-UHFFFAOYSA-N dimethyl-[3-(octadecanoylamino)propyl]azanium;chloride Chemical compound Cl.CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C LVXUNJWLKCUTNF-UHFFFAOYSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 150000002314 glycerols Chemical class 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-M glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 2
- XYSJYAQKIAGPFT-UHFFFAOYSA-N heptatriacontan-19-ylazanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCC([NH3+])CCCCCCCCCCCCCCCCCC XYSJYAQKIAGPFT-UHFFFAOYSA-N 0.000 description 2
- 239000008240 homogeneous mixture Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000008173 hydrogenated soybean oil Substances 0.000 description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 2
- 230000002209 hydrophobic Effects 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-M laurate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 2
- 229940070765 laurate Drugs 0.000 description 2
- 229940071188 lauroamphodiacetate Drugs 0.000 description 2
- 229940049918 linoleate Drugs 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 239000008204 materials by function Substances 0.000 description 2
- 229960002509 miconazole Drugs 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000011528 polyamide (building material) Substances 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000011496 polyurethane foam Substances 0.000 description 2
- 230000002829 reduced Effects 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 239000008165 rice bran oil Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- HFQBFCSVHWJVNK-UHFFFAOYSA-N sodium;2-[1-(2-hydroxyethyl)-2-undecyl-4,5-dihydroimidazol-1-ium-1-yl]acetate Chemical compound [Na+].CCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O HFQBFCSVHWJVNK-UHFFFAOYSA-N 0.000 description 2
- ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 description 2
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 2
- 239000002993 sponge (artificial) Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 235000020238 sunflower seed Nutrition 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 150000004072 triols Chemical class 0.000 description 2
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000002888 zwitterionic surfactant Substances 0.000 description 2
- VQOXZBDYSJBXMA-NQTDYLQESA-N (1S,3R,4E,6E,8E,10E,14E,16E,18S,19R,20R,21S,25R,27R,29R,32R,33R,35S,37S,38R)-3-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,29,32,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,14, Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- CIDUJQMULVCIBT-MQDUPKMGSA-N (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](NC)[C@@](C)(O)CO1)O)NCC)[C@H]1OC(CN)=CC[C@H]1N CIDUJQMULVCIBT-MQDUPKMGSA-N 0.000 description 1
- AGFWIZQEWFGATK-UNZHCMSXSA-N (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;sulfuric acid Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](NC)[C@@](C)(O)CO1)O)NCC)[C@H]1OC(CN)=CC[C@H]1N.O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](NC)[C@@](C)(O)CO1)O)NCC)[C@H]1OC(CN)=CC[C@H]1N AGFWIZQEWFGATK-UNZHCMSXSA-N 0.000 description 1
- LJRDOKAZOAKLDU-UDXJMMFXSA-N (2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfuric ac Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO LJRDOKAZOAKLDU-UDXJMMFXSA-N 0.000 description 1
- AUODDLQVRAJAJM-XJQDNNTCSA-N (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride Chemical compound Cl.CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 AUODDLQVRAJAJM-XJQDNNTCSA-N 0.000 description 1
- OIQXFRANQVWXJF-QBFSEMIESA-N (2Z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 1
- VCOPTHOUUNAYKQ-WBTCAYNUSA-N (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3S)-3,6-diamino-N-[[(2S,5S,8 Chemical compound N1C(=O)\C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1.N1C(=O)\C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1 VCOPTHOUUNAYKQ-WBTCAYNUSA-N 0.000 description 1
- VXPSARQTYDZXAO-CCHMMTNSSA-N (4S,4aR,5S,5aR,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydron;chloride Chemical compound Cl.C=C1C2=CC=CC(O)=C2C(O)=C2[C@@H]1[C@H](O)[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O VXPSARQTYDZXAO-CCHMMTNSSA-N 0.000 description 1
- PTNZGHXUZDHMIQ-CVHRZJFOSA-N (4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O PTNZGHXUZDHMIQ-CVHRZJFOSA-N 0.000 description 1
- SVDOODSCHVSYEK-IFLJXUKPSA-N (4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydron;chloride Chemical compound Cl.C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O SVDOODSCHVSYEK-IFLJXUKPSA-N 0.000 description 1
- DHPRQBPJLMKORJ-XRNKAMNCSA-N (4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O DHPRQBPJLMKORJ-XRNKAMNCSA-N 0.000 description 1
- QYAPHLRPFNSDNH-LYNLVHCPSA-N (4S,4aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC(Cl)=C2[C@](O)(C)C3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O QYAPHLRPFNSDNH-LYNLVHCPSA-N 0.000 description 1
- LCJRHAPPMIUHLH-UHFFFAOYSA-N 1-$l^{1}-azanylhexan-1-one Chemical compound [CH]CCCCC([N])=O LCJRHAPPMIUHLH-UHFFFAOYSA-N 0.000 description 1
- MWKFXSUHUHTGQN-UHFFFAOYSA-N 1-Decanol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 1
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N 1-Tetradecanol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- VUQPJRPDRDVQMN-UHFFFAOYSA-N 1-chlorooctadecane Chemical compound CCCCCCCCCCCCCCCCCCCl VUQPJRPDRDVQMN-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- MMMPXNOKIZOWHM-UHFFFAOYSA-N 1-octoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCC MMMPXNOKIZOWHM-UHFFFAOYSA-N 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1-octoxyoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- AFENDNXGAFYKQO-UHFFFAOYSA-N 2-Hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 description 1
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-Methyl-2,4-pentanediol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-Methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- TYCOFFBAZNSQOJ-UHFFFAOYSA-N 2-[4-(3-fluorophenyl)phenyl]propanoic acid Chemical compound C1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC(F)=C1 TYCOFFBAZNSQOJ-UHFFFAOYSA-N 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N 2-[6-[[amino-[[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine;hydron;dichloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- AMRBZKOCOOPYNY-QXMHVHEDSA-N 2-[dimethyl-[(Z)-octadec-9-enyl]azaniumyl]acetate Chemical compound CCCCCCCC\C=C/CCCCCCCC[N+](C)(C)CC([O-])=O AMRBZKOCOOPYNY-QXMHVHEDSA-N 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N 2-[dodecanoyl(methyl)amino]acetic acid Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- TYIOVYZMKITKRO-UHFFFAOYSA-N 2-[hexadecyl(dimethyl)azaniumyl]acetate Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)CC([O-])=O TYIOVYZMKITKRO-UHFFFAOYSA-N 0.000 description 1
- OBWBSSIUKXEALB-UHFFFAOYSA-N 2-aminoethanol;2-hydroxypropanamide Chemical compound NCCO.CC(O)C(N)=O OBWBSSIUKXEALB-UHFFFAOYSA-N 0.000 description 1
- VHBSECWYEFJRNV-UHFFFAOYSA-N 2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1O.OC(=O)C1=CC=CC=C1O VHBSECWYEFJRNV-UHFFFAOYSA-N 0.000 description 1
- JRHWHSJDIILJAT-UHFFFAOYSA-N 2-hydroxypentanoic acid Chemical compound CCCC(O)C(O)=O JRHWHSJDIILJAT-UHFFFAOYSA-N 0.000 description 1
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methylpentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 1
- DQAKJEWZWDQURW-UHFFFAOYSA-N 2-oxopyrrolidine-1-carboxylic acid Chemical class OC(=O)N1CCCC1=O DQAKJEWZWDQURW-UHFFFAOYSA-N 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N 2-phenyl-3H-benzimidazole-5-sulfonic acid Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- ILYSAKHOYBPSPC-UHFFFAOYSA-N 2-phenylbenzoic acid Chemical class OC(=O)C1=CC=CC=C1C1=CC=CC=C1 ILYSAKHOYBPSPC-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-O 4,5-dihydro-1H-imidazol-1-ium Chemical compound C1CN=C[NH2+]1 MTNDZQHUAFNZQY-UHFFFAOYSA-O 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-Aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- HEOCBCNFKCOKBX-SDNWHVSQSA-N 4-Methylbenzylidene camphor Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)C2(C)CCC\1C2(C)C HEOCBCNFKCOKBX-SDNWHVSQSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UMZBRFQRSA-N 4-[(3R,5S,7R,12S)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid Chemical class C([C@H]1C[C@H]2O)[C@H](O)CCC1(C)C1C2C2CCC(C(CCC(O)=O)C)C2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-UMZBRFQRSA-N 0.000 description 1
- SUXLANSZRSDYOX-UHFFFAOYSA-N 4-[6-(4-carbamimidoylphenoxy)hexoxy]benzenecarboximidamide;2-hydroxyethanesulfonic acid Chemical compound OCCS(O)(=O)=O.C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1 SUXLANSZRSDYOX-UHFFFAOYSA-N 0.000 description 1
- JDVPQXZIJDEHAN-UHFFFAOYSA-M 4-amino-4-oxobutanoate Chemical class NC(=O)CCC([O-])=O JDVPQXZIJDEHAN-UHFFFAOYSA-M 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- BDQHDFBEAFMWII-UHFFFAOYSA-N 6-hydroxyhexanal;hydrochloride Chemical compound Cl.OCCCCCC=O BDQHDFBEAFMWII-UHFFFAOYSA-N 0.000 description 1
- 229960004308 ACETYLCYSTEINE Drugs 0.000 description 1
- 229940035676 ANALGESICS Drugs 0.000 description 1
- FPHLBGOJWPEVME-UHFFFAOYSA-N Alminoprofen Chemical compound OC(=O)C(C)C1=CC=C(NCC(C)=C)C=C1 FPHLBGOJWPEVME-UHFFFAOYSA-N 0.000 description 1
- 241000487074 Alosa alosa Species 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N Amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N Ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- 229940114079 Arachidonic Acid Drugs 0.000 description 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N Arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-N Behenic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 1
- 229960005274 Benzocaine Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N Benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 229940093761 Bile Salts Drugs 0.000 description 1
- LEBVLXFERQHONN-UHFFFAOYSA-N Bupivacaine Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- FXALIOUHXMVTMJ-UHFFFAOYSA-N CCCCCCCCCCCC([Na])=O Chemical compound CCCCCCCCCCCC([Na])=O FXALIOUHXMVTMJ-UHFFFAOYSA-N 0.000 description 1
- DLQDPUCZIABCES-VZBBZXSKSA-N CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)[C@H](OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)[C@@H](OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)C=O Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)[C@H](OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)[C@@H](OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)C=O DLQDPUCZIABCES-VZBBZXSKSA-N 0.000 description 1
- GGQJXCQBBONZFX-IWVLMIASSA-N CHEMBL1237124 Chemical compound C=C([C@H]1[C@@H]2O)C3=C(Cl)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O GGQJXCQBBONZFX-IWVLMIASSA-N 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Calypsol Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- JNIIDKODPGHQSS-DHDCSXOGSA-N Capreomycin Chemical compound N1C(=O)\C(=C\NC(N)=O)NC(=O)C(CNC(=O)CC(N)CCCN)NC(=O)C(CO)NC(=O)C(N)CNC(=O)C1C1NC(N)=NCC1 JNIIDKODPGHQSS-DHDCSXOGSA-N 0.000 description 1
- 108010065839 Capreomycin Proteins 0.000 description 1
- 229960002968 Capreomycin Sulfate Drugs 0.000 description 1
- IVUMCTKHWDRRMH-UHFFFAOYSA-N Carprofen Chemical compound C1=CC(Cl)=C[C]2C3=CC=C(C(C(O)=O)C)C=C3N=C21 IVUMCTKHWDRRMH-UHFFFAOYSA-N 0.000 description 1
- 229920002301 Cellulose acetate Polymers 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N Cetyl alcohol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- DJHJJVWPFGHIPH-OODMECLYSA-N Chitin Chemical compound O[C@@H]1C(NC(=O)C)[C@H](O)OC(CO)[C@H]1COC[C@H]1C(NC(C)=O)[C@@H](O)[C@H](COC[C@H]2C([C@@H](O)[C@H](O)C(CO)O2)NC(C)=O)C(CO)O1 DJHJJVWPFGHIPH-OODMECLYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229960003260 Chlorhexidine Drugs 0.000 description 1
- 229960004504 Chlorhexidine Hydrochloride Drugs 0.000 description 1
- 229960002023 Chloroprocaine Drugs 0.000 description 1
- VDANGULDQQJODZ-UHFFFAOYSA-N Chloroprocaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 description 1
- 229960004475 Chlortetracycline Drugs 0.000 description 1
- 239000004099 Chlortetracycline Substances 0.000 description 1
- 229960003185 Chlortetracycline Hydrochloride Drugs 0.000 description 1
- 229940107161 Cholesterol Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N Cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 241001340526 Chrysoclista linneella Species 0.000 description 1
- PUFQVTATUTYEAL-UHFFFAOYSA-N Cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N Ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N Clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960001200 Clindamycin Hydrochloride Drugs 0.000 description 1
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-Threitol Natural products OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 1
- SNPLKNRPJHDVJA-UHFFFAOYSA-N DL-Panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 1
- 229960004082 DOXYCYCLINE HYDROCHLORIDE Drugs 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 229940009976 Deoxycholate Drugs 0.000 description 1
- 229940120099 Dibucaine Drugs 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N Dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M Dioctyl sodium sulfosuccinate Chemical group [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N Dodecanol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229960003722 Doxycycline Drugs 0.000 description 1
- 102100009766 ETDA Human genes 0.000 description 1
- 101700027496 ETDA Proteins 0.000 description 1
- 239000001692 EU approved anti-caking agent Substances 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 210000002615 Epidermis Anatomy 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- 229940009714 Erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N Erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229960003203 Erythromycin Estolate Drugs 0.000 description 1
- AEUTYOVWOVBAKS-UWVGGRQHSA-N Ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 1
- 229960000285 Ethambutol Drugs 0.000 description 1
- 229960001618 Ethambutol Hydrochloride Drugs 0.000 description 1
- 229960003976 Etidocaine Drugs 0.000 description 1
- VTUSIVBDOCDNHS-UHFFFAOYSA-N Etidocaine Chemical compound CCCN(CC)C(CC)C(=O)NC1=C(C)C=CC=C1C VTUSIVBDOCDNHS-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Exidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 210000001508 Eye Anatomy 0.000 description 1
- ZPAKPRAICRBAOD-UHFFFAOYSA-N Fenbufen Chemical compound C1=CC(C(=O)CCC(=O)O)=CC=C1C1=CC=CC=C1 ZPAKPRAICRBAOD-UHFFFAOYSA-N 0.000 description 1
- 229960001419 Fenoprofen Drugs 0.000 description 1
- RDJGLLICXDHJDY-UHFFFAOYSA-N Fenoprofen Chemical compound OC(=O)C(C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-UHFFFAOYSA-N 0.000 description 1
- 229950001284 Fluprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N Flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- 240000006669 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- DCAYPVUWAIABOU-UHFFFAOYSA-N Hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N Hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N Hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- DKLKMKYDWHYZTD-UHFFFAOYSA-N Hexylcaine Chemical compound C=1C=CC=CC=1C(=O)OC(C)CNC1CCCCC1 DKLKMKYDWHYZTD-UHFFFAOYSA-N 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N Hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- RJMIEHBSYVWVIN-UHFFFAOYSA-N Indoprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1N1C(=O)C2=CC=CC=C2C1 RJMIEHBSYVWVIN-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N Isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N Kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N Ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 229940001447 Lactate Drugs 0.000 description 1
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 1
- 229960004393 Lidocaine Hydrochloride Drugs 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- MHIGBKBJSQVXNH-IWVLMIASSA-N Metacycline Chemical compound C=C([C@H]1[C@@H]2O)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O MHIGBKBJSQVXNH-IWVLMIASSA-N 0.000 description 1
- 229940042016 Methacycline Drugs 0.000 description 1
- 229960004011 Methenamine Drugs 0.000 description 1
- 229960000282 Metronidazole Drugs 0.000 description 1
- 229960004023 Minocycline Drugs 0.000 description 1
- DYKFCLLONBREIL-KVUCHLLUSA-N Minocycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 description 1
- 229960002421 Minocycline Hydrochloride Drugs 0.000 description 1
- 210000004400 Mucous Membrane Anatomy 0.000 description 1
- JEJSGFPNNFSSNI-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)tetradecan-1-amine oxide Chemical compound CCCCCCCCCCCCCC[N+]([O-])(CCO)CCO JEJSGFPNNFSSNI-UHFFFAOYSA-N 0.000 description 1
- MECBYDXMJQGFGQ-UHFFFAOYSA-N N,N-dimethylethanamine oxide Chemical compound CC[N+](C)(C)[O-] MECBYDXMJQGFGQ-UHFFFAOYSA-N 0.000 description 1
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine zwitterion Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 1
- IBOBFGGLRNWLIL-UHFFFAOYSA-N N,N-dimethylhexadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)[O-] IBOBFGGLRNWLIL-UHFFFAOYSA-N 0.000 description 1
- QMDUPVPMPVZZGK-UHFFFAOYSA-N N,N-dimethyloctadecan-1-amine;hydrobromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[NH+](C)C QMDUPVPMPVZZGK-UHFFFAOYSA-N 0.000 description 1
- RSVIRMFSJVHWJV-UHFFFAOYSA-N N,N-dimethyloctan-1-amine oxide Chemical compound CCCCCCCC[N+](C)(C)[O-] RSVIRMFSJVHWJV-UHFFFAOYSA-N 0.000 description 1
- UNAFTICPPXVTTN-UHFFFAOYSA-N N-dodecyldodecan-1-amine;hydrobromide Chemical compound [Br-].CCCCCCCCCCCC[NH2+]CCCCCCCCCCCC UNAFTICPPXVTTN-UHFFFAOYSA-N 0.000 description 1
- ALQWDAJTEFASRJ-UHFFFAOYSA-N N-hexadecylhexadecan-1-amine;hydrochloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[NH2+]CCCCCCCCCCCCCCCC ALQWDAJTEFASRJ-UHFFFAOYSA-N 0.000 description 1
- LOCYSVHOSYQGOV-UHFFFAOYSA-N N-hexyl-6-$l^{1}-azanyl-6-oxohexanamide Chemical compound [CH]CCCCCNC(=O)CCCCC([N])=O LOCYSVHOSYQGOV-UHFFFAOYSA-N 0.000 description 1
- WVMBPWMAQDVZCM-UHFFFAOYSA-N N-methylanthranilic acid Chemical compound CNC1=CC=CC=C1C(O)=O WVMBPWMAQDVZCM-UHFFFAOYSA-N 0.000 description 1
- ZLDPNFYTUDQDMJ-UHFFFAOYSA-N N-octadecyloctadecan-1-amine;hydrobromide Chemical compound Br.CCCCCCCCCCCCCCCCCCNCCCCCCCCCCCCCCCCCC ZLDPNFYTUDQDMJ-UHFFFAOYSA-N 0.000 description 1
- GMMYSKGRQQKXIU-UHFFFAOYSA-N N-tetradecyltetradecan-1-amine;hydrochloride Chemical compound Cl.CCCCCCCCCCCCCCNCCCCCCCCCCCCCC GMMYSKGRQQKXIU-UHFFFAOYSA-N 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N Neomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 229940053050 Neomycin Sulfate Drugs 0.000 description 1
- 229960000808 Netilmicin Drugs 0.000 description 1
- 229960004832 Netilmicin Sulfate Drugs 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 229920000305 Nylon 6,10 Polymers 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- URSCRKIYUPROKB-PHHCKKAISA-N OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O URSCRKIYUPROKB-PHHCKKAISA-N 0.000 description 1
- 229960003921 Octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N Octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl methoxycinnamate Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Octyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 229940049964 Oleate Drugs 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N Oleyl alcohol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- MITFXPHMIHQXPI-UHFFFAOYSA-N Oraflex Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 1
- OFPXSFXSNFPTHF-UHFFFAOYSA-N Oxaprozin Chemical compound O1C(CCC(=O)O)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 OFPXSFXSNFPTHF-UHFFFAOYSA-N 0.000 description 1
- 229960000625 Oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N Oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 229960004368 Oxytetracycline Hydrochloride Drugs 0.000 description 1
- 229940078492 PPG-17 Drugs 0.000 description 1
- 229960005065 Paromomycin Sulfate Drugs 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- DQKXQSGTHWVTAD-UHFFFAOYSA-N Pramocaine Chemical compound C1=CC(OCCCC)=CC=C1OCCCN1CCOCC1 DQKXQSGTHWVTAD-UHFFFAOYSA-N 0.000 description 1
- TVQZAMVBTVNYLA-UHFFFAOYSA-N Pranoprofen Chemical compound C1=CC=C2CC3=CC(C(C(O)=O)C)=CC=C3OC2=N1 TVQZAMVBTVNYLA-UHFFFAOYSA-N 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N Procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N Raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 229940080236 SODIUM CETYL SULFATE Drugs 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229940058287 Salicylic acid derivative anticestodals Drugs 0.000 description 1
- 240000003670 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 210000004927 Skin cells Anatomy 0.000 description 1
- 229940045998 Sodium Isethionate Drugs 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M Sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 229940031439 Squalene Drugs 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N Stearyl alcohol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 229960005322 Streptomycin Drugs 0.000 description 1
- 229960002385 Streptomycin Sulfate Drugs 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 229960004492 Suprofen Drugs 0.000 description 1
- MDKGKXOCJGEUJW-UHFFFAOYSA-N Suprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1C(=O)C1=CC=CS1 MDKGKXOCJGEUJW-UHFFFAOYSA-N 0.000 description 1
- 229960002372 Tetracaine Drugs 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N Tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- 229960000707 Tobramycin Drugs 0.000 description 1
- 229960004477 Tobramycin Sulfate Drugs 0.000 description 1
- FUSNMLFNXJSCDI-UHFFFAOYSA-N Tolnaftate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=S)N(C)C1=CC=CC(C)=C1 FUSNMLFNXJSCDI-UHFFFAOYSA-N 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- 229940029983 VITAMINS Drugs 0.000 description 1
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 1
- 210000002268 Wool Anatomy 0.000 description 1
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N Xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 Xylitol Drugs 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Xylocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 229960003487 Xylose Drugs 0.000 description 1
- OTPSWLRZXRHDNX-UHFFFAOYSA-L Zinc pyrithione Chemical compound S1C2=CC=CC=N2=O[Zn]21O=N1=CC=CC=C1S2 OTPSWLRZXRHDNX-UHFFFAOYSA-L 0.000 description 1
- SCMSRHIBVBIECI-UHFFFAOYSA-N [2-hydroxy-4-(2-hydroxyethoxy)phenyl]-phenylmethanone Chemical compound OC1=CC(OCCO)=CC=C1C(=O)C1=CC=CC=C1 SCMSRHIBVBIECI-UHFFFAOYSA-N 0.000 description 1
- 238000005296 abrasive Methods 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- DHFCLYNGVLPKPK-UHFFFAOYSA-N acetamide;2-aminoethanol Chemical compound CC(N)=O.NCCO DHFCLYNGVLPKPK-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229960004663 alminoprofen Drugs 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 229940077484 ammonium bromide Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 229940051879 analgesics and antipyretics Salicylic acid and derivatives Drugs 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- OADXQALOSREDRB-UHFFFAOYSA-N azanium;hexadecyl sulfate Chemical compound N.CCCCCCCCCCCCCCCCOS(O)(=O)=O OADXQALOSREDRB-UHFFFAOYSA-N 0.000 description 1
- 229960002255 azelaic acid Drugs 0.000 description 1
- 230000001580 bacterial Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960005430 benoxaprofen Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-M benzoate Chemical compound [O-]C(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-M 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960004602 capreomycin Drugs 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 238000009960 carding Methods 0.000 description 1
- 229960003184 carprofen Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229960001747 cinchocaine Drugs 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 229940079840 cocoyl isethionate Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- ZRKZFNZPJKEWPC-UHFFFAOYSA-N decylamine-N,N-dimethyl-N-oxide Chemical compound CCCCCCCCCC[N+](C)(C)[O-] ZRKZFNZPJKEWPC-UHFFFAOYSA-N 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-M deoxycholate Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-M 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- RNMIVNUNMNQFRD-UHFFFAOYSA-N dihexadecylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[NH2+]CCCCCCCCCCCCCCCC RNMIVNUNMNQFRD-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- PFKRTWCFCOUBHS-UHFFFAOYSA-N dimethyl(octadecyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[NH+](C)C PFKRTWCFCOUBHS-UHFFFAOYSA-N 0.000 description 1
- DKJLEUVQMKPSHB-UHFFFAOYSA-N dimethyl-[3-(octadecanoylamino)propyl]-(2-oxo-2-tetradecoxyethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCCCC DKJLEUVQMKPSHB-UHFFFAOYSA-N 0.000 description 1
- NTLIJZACUWTZFB-UHFFFAOYSA-N dimethyl-[3-(octadecanoylamino)propyl]azanium;2-hydroxypropanoate Chemical compound CC(O)C(O)=O.CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C NTLIJZACUWTZFB-UHFFFAOYSA-N 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-O dimethylaminium Chemical compound C[NH2+]C ROSDSFDQCJNGOL-UHFFFAOYSA-O 0.000 description 1
- JZZIHCLFHIXETF-UHFFFAOYSA-N dimethylsilicon Chemical compound C[Si]C JZZIHCLFHIXETF-UHFFFAOYSA-N 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- HOWGUJZVBDQJKV-UHFFFAOYSA-N docosane Chemical compound CCCCCCCCCCCCCCCCCCCCCC HOWGUJZVBDQJKV-UHFFFAOYSA-N 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecan-1-amine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- VZXFEELLBDNLAL-UHFFFAOYSA-N dodecan-1-amine;hydrobromide Chemical compound [Br-].CCCCCCCCCCCC[NH3+] VZXFEELLBDNLAL-UHFFFAOYSA-N 0.000 description 1
- TWFQJFPTTMIETC-UHFFFAOYSA-N dodecan-1-amine;hydron;chloride Chemical compound [Cl-].CCCCCCCCCCCC[NH3+] TWFQJFPTTMIETC-UHFFFAOYSA-N 0.000 description 1
- JBIWCJUYHHGXTC-AKNGSSGZSA-N doxycycline Chemical compound O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O JBIWCJUYHHGXTC-AKNGSSGZSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- AWMFUEJKWXESNL-JZBHMOKNSA-N erythromycin estolate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O.O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)OC(=O)CC)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AWMFUEJKWXESNL-JZBHMOKNSA-N 0.000 description 1
- 229950001028 erythromycin propionate Drugs 0.000 description 1
- 229960004142 erythromycin stearate Drugs 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-M ethyl sulfate Chemical compound CCOS([O-])(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-M 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229960001395 fenbufen Drugs 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229930003935 flavonoids Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229920005570 flexible polymer Polymers 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- YNDMEEULGSTYJT-LURJTMIESA-N foslevodopa Chemical compound OC(=O)[C@@H](N)CC1=CC=C(OP(O)(O)=O)C(O)=C1 YNDMEEULGSTYJT-LURJTMIESA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
- 230000003699 hair surface Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- NMIYNWDARZCKJG-UHFFFAOYSA-N heptatriacontan-19-ylazanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCCC([NH3+])CCCCCCCCCCCCCCCCCC NMIYNWDARZCKJG-UHFFFAOYSA-N 0.000 description 1
- XQSBLCWFZRTIEO-UHFFFAOYSA-N hexadecan-1-amine;hydrobromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[NH3+] XQSBLCWFZRTIEO-UHFFFAOYSA-N 0.000 description 1
- URXQDXAVUYKSCK-UHFFFAOYSA-N hexadecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[NH+](C)C URXQDXAVUYKSCK-UHFFFAOYSA-N 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 229960001715 hexamidine isethionate Drugs 0.000 description 1
- TZMQHOJDDMFGQX-UHFFFAOYSA-N hexane-1,1,1-triol Chemical compound CCCCCC(O)(O)O TZMQHOJDDMFGQX-UHFFFAOYSA-N 0.000 description 1
- 229960005388 hexylcaine Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229940091173 hydantoin Drugs 0.000 description 1
- XPXMKIXDFWLRAA-UHFFFAOYSA-N hydrazinide Chemical class [NH-]N XPXMKIXDFWLRAA-UHFFFAOYSA-N 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 description 1
- 239000010514 hydrogenated cottonseed oil Substances 0.000 description 1
- 239000010512 hydrogenated peanut oil Substances 0.000 description 1
- RNYJXPUAFDFIQJ-UHFFFAOYSA-N hydron;octadecan-1-amine;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[NH3+] RNYJXPUAFDFIQJ-UHFFFAOYSA-N 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 description 1
- 229960004187 indoprofen Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 229910000460 iron oxide Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 230000001530 keratinolytic Effects 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940071145 lauroyl sarcosinate Drugs 0.000 description 1
- 229940071204 lauryl sarcosinate Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- QZZGJDVWLFXDLK-UHFFFAOYSA-M lignocerate Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC([O-])=O QZZGJDVWLFXDLK-UHFFFAOYSA-M 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000011068 load Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 229960000826 meclocycline Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 229960002409 mepivacaine Drugs 0.000 description 1
- INWLQCZOYSRPNW-UHFFFAOYSA-N mepivacaine Chemical compound CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C INWLQCZOYSRPNW-UHFFFAOYSA-N 0.000 description 1
- 229960003494 metacycline Drugs 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- GLMUAFMGXXHGLU-VQAITOIOSA-N minocycline hydrochloride Chemical compound [H+].[Cl-].C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O GLMUAFMGXXHGLU-VQAITOIOSA-N 0.000 description 1
- 230000003020 moisturizing Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000002365 multiple layer Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 150000002829 nitrogen Chemical group 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- YHIXOVNFGQWPFW-UHFFFAOYSA-N octadecan-1-amine;hydrobromide Chemical compound [Br-].CCCCCCCCCCCCCCCCCC[NH3+] YHIXOVNFGQWPFW-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-M oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC([O-])=O ZQPPMHVWECSIRJ-KTKRTIGZSA-M 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N oxane Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229960002739 oxaprozin Drugs 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- NJRWNWYFPOFDFN-UHFFFAOYSA-L phosphonate(2-) Chemical compound [O-][P]([O-])=O NJRWNWYFPOFDFN-UHFFFAOYSA-L 0.000 description 1
- 230000003711 photoprotective Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001888 polyacrylic acid Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 229960001896 pramocaine Drugs 0.000 description 1
- 229960003101 pranoprofen Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002335 preservative Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- HCWPIIXVSYCSAN-UHFFFAOYSA-N radium Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 description 1
- 229910052705 radium Inorganic materials 0.000 description 1
- 239000003638 reducing agent Substances 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 125000000946 retinyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C([H])=C(C([H])([H])[H])/C([H])=C([H])/C1=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])([H])C1(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 150000005619 secondary aliphatic amines Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 125000005373 siloxane group Chemical group [SiH2](O*)* 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 231100000051 skin sensitiser Toxicity 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 150000003385 sodium Chemical class 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- HYHAWELIVMOSBT-UHFFFAOYSA-M sodium;2-aminopentadecanoate Chemical compound [Na+].CCCCCCCCCCCCCC(N)C([O-])=O HYHAWELIVMOSBT-UHFFFAOYSA-M 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- DIORMHZUUKOISG-UHFFFAOYSA-M sulfoformate Chemical compound OC(=O)S([O-])(=O)=O DIORMHZUUKOISG-UHFFFAOYSA-M 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000004808 supercritical fluid chromatography Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003510 tertiary aliphatic amines Chemical class 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229960005196 titanium dioxide Drugs 0.000 description 1
- 229960004880 tolnaftate Drugs 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 230000000699 topical Effects 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
- 150000003668 tyrosines Chemical class 0.000 description 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamins Natural products 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- MNFORVFSTILPAW-UHFFFAOYSA-N Β-Lactam Chemical compound O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 description 1
Abstract
The present invention relates to a substantially dry, disposable, personal cleansing product useful for both cleansing and conditioning the skin or hair. These products are used by the consumer by wetting the dry product with water. The product comprises a water insoluble substrate, a lathering surfactant, and an oil soluble conditioning agent. The invention also encompasses methods for cleansing and conditioning the skin or hair using these products and to methods for manufacturing these products.
Description
CLEANING PRODUCTS
TECHNICAL FIELD
The present invention relates to a substantially clean and disposable personal cleaning product useful both for cleaning and conditioning the skin or hair. These products are used by the consumer when moistening the dry product with water. The product includes a water-insoluble substrate, a foaming surfactant and an oil-soluble conditioning agent. The use of substrates increases foaming at low surfactant levels, increases cleaning and exfoliation and optimizes the supply and deposition of conditioning ingredients. As a result, this invention provides effective cleaning using lower, and therefore less irritating, levels of surfactant while providing superior conditioning benefits. The invention also encompasses products that include various active ingredients for delivery to the skin or hair. The invention also encompasses a method for cleaning and moisturizing the skin and hair, using the products of the present invention and also methods for making these products.
BACKGROUND OF THE INVENTION
Traditionally, personal cleansing products have been marketed in a variety of forms such as bar soaps, creams, lotions and gels. These cleaning formulations have tried to satisfy a number of criteria in order to be acceptable to consumers. These criteria include cleaning effectiveness, sensitivity to the skin, softness to the skin, hair, eye mucous membranes and foaming volume. Ideal personal cleansers should carefully cleanse the skin or hair, cause a slight irritation or not cause irritation, and not leave the skin or hair too dry after frequent use. However, these traditional forms of personal cleansing products have the problem inherent in balancing the cleaning effectiveness against the supply of a conditioning benefit. One solution to this problem is to use separate cleaning products and conditioners. However, this is not always convenient or practical and many consumers would prefer to use a unique product that can both cleanse and condition the skin or hair. In a typical cleaning composition, the conditioning ingredients are difficult to formulate, since many conditioners are incompatible with the surfactants, which results in an inhomogeneous undesirable mixture. To obtain a homogenous mixture with conditioning ingredients and to prevent the loss of conditioning ingredients before the deposition,
Additional ingredients, for example, emulsifiers, thickeners and gelling agents, are often added to suspend the conditioning ingredients within the surfactant mixture. This results in an aesthetically pleasing and homogeneous mixture, but often results in poor deposition of conditioning ingredients, since the conditioners are emulsified and not released efficiently during cleaning. Also, many conditioning agents have the disadvantage of suppressing foam generation. The suppression of foam is a problem because many consumers look for cleaning products that provide a rich, creamy and generous foam. Therefore, it is seen that conventional cleaning products that try to combine surfactants and conditioning ingredients suffer from disadvantages inherently resulting from the incompatibilities of surfactants and conditioners. There is a clear need to develop cleaning systems that provide effective cleaning and still provide sufficient conditioning in a single product. Likewise, it is highly desirable to provide cleansing and conditioning benefits from a disposable, single-use product. Disposable products are convenient, since they prevent the need to load bottles, bars, jars, uncomfortable tubes and other forms of cleaning and conditioning products. Disposable products are also a more sanitary alternative than the use of a sponge, cleaning cloth or
other cleaning products proposed to be used again in multiple form, since said products develop bacterial growth, unpleasant odors and other undesirable characteristics related to repeated use. In a surprising way, it has been found in the present
Invention that the products can be developed to provide effective cleaning and conditioning in a convenient, cheap, disposable and sanitary personal cleaning product. The present invention provides the convenience of not needing the use of separate cleaning and conditioning products. The present invention is highly convenient for use, since it is in the form of a substantially dry product that is moistened before use. The present invention relates to a dry, disposable personal cleansing product useful both for cleaning and conditioning of hair or skin. These products are used by the consumer when moistening the dry product with water. The product consists of a substrate insoluble in water, a surfactant and a conditioner. Without being limited to theory, it is believed that the substrate increases foaming at low levels of surfactant, increases cleaning and exfoliation and optimizes the assortment and deposition of packaging ingredients. As a result, this invention provides effective cleaning by using lower, and therefore less irritating, levels of surfactant, while providing superior conditioning benefits. Also, it has been found
that these products are useful to supply a wide range of active ingredients for the skin or hair during the cleaning procedure. Therefore, an object of the present invention is to provide substantially dry products for cleaning and conditioning the characterized skin or hair because the products are used in combination with water. It is another object of the present invention to provide products that include a water insoluble substrate, a surfactant and a conditioning component. Another object of the present invention is to provide products that are disposable and proposed for single use. It is another object of the present invention to provide products that are soft to the skin or hair. It is another object of the present invention to provide products useful for delivering active ingredients to the skin or hair during the cleaning and conditioning process. It is another object of the present invention to provide cleaning and conditioning methods to the skin or hair. It is another object of the present invention to provide methods of manufacturing the products of the present invention. This and other objects of this invention will be apparent in the light of the following description.
BRIEF DESCRIPTION OF THE INVENTION
The present invention relates to a disposable cleaning and conditioning product, for personal care and single use, which includes: (A) a water-insoluble substrate, (B) a foaming surfactant, and (C) a conditioning agent soluble in water. oil, wherein said cleaning product deposits an amount greater than about 2.5 μg / cm2 of said oil-soluble conditioning agent to the surface of the skin or hair, and wherein said product is substantially dry. In other embodiments, the present invention relates to a disposable personal care and disposable cleaning and conditioning product that includes: (A) a water insoluble substrate, and (B) a cleaning and conditioning composition that includes: (1) ) a foaming surfactant, and (ii) an oil-soluble conditioning agent, wherein said foaming agent and said oil-soluble conditioning agent are added or impregnated separately or simultaneously in said water-insoluble substrate, and wherein the ratio of The weight of the foaming surfactant to the oil-soluble conditioning agent is less than about 20: 1, wherein said cleaning agent deposits
an amount greater than about 2.5 μg / cm of said oil-soluble conditioning agent to the surface of the skin or hair and wherein said product is substantially dry. In other embodiments, the present invention relates to a method of manufacturing a disposable personal care and disposable cleaning and conditioning product, which includes the step of adding or impregnating separately or simultaneously into a water insoluble substrate.
(A) a foaming surfactant, and (B) an oil-soluble conditioning agent, wherein the weight ratio of the foaming surfactant to the oil-soluble conditioning agent is less than about 20: 1, wherein said cleaning products deposit an amount greater than about 2.5 μg / cm2 of said oil-soluble conditioning agent to the surface of the skin or hair, and wherein said resulting product is substantially dry. In other embodiments, the present invention relates to methods for cleaning and conditioning the hair or skin with the personal cleansing products described herein. In still other embodiments, the present invention relates to methods for depositing conditioning agents on the skin or hair. All percentages and ratios used herein, unless otherwise specified, are by weight and all measurements made are at 25 ° C, except those otherwise designated. The Invention of
present may include, consist of, or consist essentially of essential ingredients and components, as well as optional ingredients and components described herein.
DETAILED DESCRIPTION OF THE INVENTION
The personal cleansers of the present invention are highly effective in cleaning hair or skin, and still provide effective deposition of conditioning agents. The products may also contain other active ingredients that can be deposited on the skin or hair. Without being limited to theory, it is believed that the substrate contributes significantly to the generation of foam and deposition of conditioning agents and other active ingredients. It is believed that this increase in foaming is the result of the action on the surface of the substrate. As a result, milder and significantly lower amounts of surfactants can be employed. It is believed that the reduced amount of surfactant required is related to the reduction in the drying effect of the skin or hair by the surfactants. In addition, the reduced amount of the surfactant drastically decreases the inhibitory action (for example, via emulsification or direct removal by the surfactants) or surfactants to deposit the conditioning agents.
Without being limited to theory, the substrate also increases the deposition of conditioning agents and active ingredients. Since the invention is in dry form, the invention does not require emulsifiers that inhibit the deposition of conditioning agents and active ingredients. In addition, since the skin conditioners and active ingredients are dried or impregnated in the substrate, they are transferred directly to the skin or hair by contacting the surface of the moist product with the skin. Finally, the substrate also increases the cleanliness. The substrate may have different textures on each side, for example a rough side and a smooth side. The substrate acts as an effective foaming agent and an exfoliating product. By physically coming in contact with skin or hair, the substrate significantly helps to clean and remove dirt, makeup, dead skin cells and other debris. By a "foaming surfactant" is meant a surfactant, which when combined with water and mechanically stirred generates a foam or suds. Preferably, these surfactants should be mild, which means that these surfactants provide sufficient cleaning or detersive benefits, but do not dry the skin or hair too much and still meet the foaming criteria described above.
The terms "disposable" or "single use" are used herein in their ordinary sense to mean a product that may be discarded or discarded after use. The term "activated in water" as used herein, means that the present invention is presented to the consumer in dry form for use after moistening it with water. It was found that these products produce a foam or are "activated" when they come into contact with water and more agitation. The term "substantially dry" as used herein means that the product is substantially free of water and usually feels dry to the touch. The products of the present invention include less than about 10% by weight of water, preferably less than about 5% by weight of water and more preferably less than about 1% by weight of water, the foregoing measured in a dry environment, for example low humidity Those skilled in the art will recognize that the water content of a product as in the present invention can vary with the relative humidity of the environment. The term "soft" as used herein in reference to the foaming surfactants and products of the present invention means that the products of the present invention demonstrate skin smoothness comparable to an alkylglyceryl ether sulphonate surfactant (AGS) based on a bar synthetic, for example synbar bar. Methods to measure the mildness or vice versa the irritability of a surfactant,
which contain the products, are based on a skin bar destruction test. In this test, while the surfactant is softer, the skin bar will be less destroyed. The destruction of the skin bar is measured by the relative amount of water marked with radium (marked with tritium) (3H-H2O) that passes from the test solution through the epidermis of the skin into a physiological pH enhancer content in the diffused camera. The test is described by T.J. Franz in J.Invest.Dermatol .. 1975,64, pp. 190-195; and in U.S. Patent No. 4,673,525 to Smail et al., issued June 16, 1987, which are hereby incorporated by reference in their entirety. Other test methodologies for determining the surfactant softness well known to those skilled in the art can also be used. The personal care products of the present invention include the following essential components. The composition, which is impregnated or applied to the substrate, consists essentially of one or more surfactants and one or more conditioning agents. Additional active ingredients may also be included within the composition. An alternative and preferred method is to apply each ingredient separately to the substrate. In embodiments where only an oil-soluble conditioning agent is required, these cleaning and conditioning products are substantially and preferably free of benzoate of C12-15 alcohols, for example free of benzoic acid esters of alcohols having
mainly from about 12 to about 15 carbon atoms. See International Cosmetic Ingredient Dictionary, Fifth Edition, 1993, p. 87, which is incorporated herein by reference in its entirety. Also, "substantially free of benzoates of C12-15 alcohols" means less than about 1%, preferably less than about 0.5% and more preferably less than about 0.25% by weight of the cleaning and conditioning composition, which includes the surfactant foaming agent and the oil-soluble conditioning agent.
SUBSTRATE INSOLUBLE IN WATER
The products of the present invention include a water insoluble substrate. By "insoluble in water" it is meant that the substrate does not dissolve in or break easily due to immersion in water. The water-insoluble substrate is the product or vehicle for supplying the foaming surfactant and the conditioning component of the present invention to the skin or hair for cleaning or conditioning. Without being limited to the theory, it is believed that the substrate, by providing mechanical stirring, provides a foaming generation effect and also aids in the deposition of the conditioning component. A wide variety of materials can be used as the substrate. The following non-limiting characteristics are desirable:
(i) sufficient wetting force to be used, (ii) sufficient abrasivity, (ni) sufficient bulging and porosity, (v) sufficient thickness and (v) appropriate size. Non-limiting examples of suitable soluble substrates meeting the aforementioned criteria include non-woven substrates, woven substrates, hydroentangled substrates, air-entangled substrates, natural sponges, synthetic sponges, meshes with net meshes and the like. Preferred embodiments are non-woven substrates, as they are economically and readily available in a variety of materials. By "non-woven" is meant that the layer comprises fibers that are not woven in a fabric, but that are formed in a layer of sheet, fibrous or pad mat. The fibers can be random (for example, randomly aligned) or can be carded (for example, carded to be oriented mainly in one direction). In addition, the non-woven substrate may be composed of a combination of carded and random fiber layers. Nonwoven substrates can include a variety of both natural and synthetic materials. By natural, it is understood that the materials are derived from plants, animals, insects or byproducts of plants, animals and insects. By synthetic, it is understood that the materials are obtained mainly from various materials made by man or from natural materials that have been altered more. The conventional base starting material
it is usually a fibrous network that includes any of the common synthetic or natural textile fibers or mixture thereof. Non-limiting examples of natural materials that are used in the present invention are silk fibers, keratin fibers and cellulosic fibers. Non-limiting examples of keratin fibers include those selected from the group consisting of wool fibers, camel hair fibers and the like. Non-limiting examples of cellulosic fibers include those selected from the group consisting of cotton pulp fibers, cotton fibers, hemp fibers, jute fibers, flax fibers and mixtures thereof. Non-limiting examples of synthetic materials useful in the present invention include those selected from the group consisting of acetate fibers, acrylic fibers, sterile cellulose fibers, modacrylic fibers, polyamide fibers, polyester fibers, polyolefin fibers, polyvinyl alcohol fibers, rayon fibers, polyurethane foam and mixtures thereof. Examples of some synthetic materials include acrylics such as acrylic, cresk and acrylonitrile-based fiber, orion; cellulose fibers such as cellulose acetate, amel and acala; polyamides such as nylon (for example, nylon 6, nylon 66, nylon 610 and the like); polyesters such as fortrel, kodel, and polyethylene terephthalate fiber, dacron; polyolefins such as polypropylene, polyethylene; polyvinyl acetate fibers; polyurethane foams and mixtures thereof. These and other suitable fibers and nonwovens prepared from them, are generally described in Riedel, "Nonwoven Bonding
Methods and Materials, "Nonwoven World (1987); The Encyclopedia
Americana, vol. 11, pp. 147-153, and vol. 26, pp. 566-581 (1984); patent of
United States No. 4,891,227, Thaman et al., Issued January 2, 1990 and United States Patent No. 4,891,228, which are hereby incorporated by reference in their entirety. Nonwoven substrates made of natural materials consist of nets or sheets more commonly formed on a screen of fine wire from a liquid fiber suspension. See C.A. Hampel et al., The Encyclopedia of Chemistry, 3rd. edition, 1973, pp. 793-795 (1973); The Encyclopedia Americana, vol. 21, pp. 376-383 (1984); and G.A. Smook, Handbook of Pulp and Paper Technologies, Technical Association for the Pulp and Paper Industry (1986); which are incorporated herein by reference in their entirety. Substrates made of natural materials that are used in the present invention can be obtained from a wide variety of commercial sources. Non-limiting examples of commercially available and suitable paper layers that are used herein include Alrtex®, an enhanced air-laid cellulosic layer having a basis weight of approximately 71 g / m2, available from James River, Green Bay, Wl; and Walkisoft®, a raised air-laid cellulosic having a basis weight of approximately 75g / m2 available from Waikisoft U.S.A., Mount Holly, NC.
Methods for making nonwoven substrates are well known in the art. Generally, these nonwoven substrates can be made
by means of methods of placement in the air, placement in water, burning melting, shaping, splicing or carding, in which the fibers or filaments are first cut to the desired length of long chains, passed in a stream of water or air and subsequently deposited on a screen through which air charged with fiber or water is passed. The resulting layer, in spite of its production method or composition, is subsequently subjected to at least one of several types of joining operations for arching the individual fibers together to form a self-supporting network. In the present invention, the non-woven layer can be prepared by a variety of processes including hydroentangling, thermal bonding or temounion and combinations of its processes. In addition, the substrates of the present invention can consist of a single layer or multiple layers. In addition, a stratified substrate multiple times can include films and other non-fibrous materials. Nonwoven substrates made of synthetic materials useful in the present invention can also be obtained from a wide variety of commercial sources. Non-limiting examples of suitable non-fibrous layer materials useful herein include HEF 40-047, a material with hydroentangling aperture containing about 50% rayon and 50% polyester and having a basis weight of about 43 grams per square yard 0.84m2, available from Veratec, Inc., Walpole, MA; HEF 140-102, a material with opening
hydroentangling containing about 50% rayon and 50% polyester and having a basis weight of about 56g / m2, available from Veratec, Inc., Walpole, MA; Novonet® 149-616, a thermo bonded grid type material containing approximately 100% polypropylene and having a basis weight of about 50g / m2 available from Veratec, Inc., Walpole, MA; Novonet® 149-801, a thermo bonded grid-like material containing about 69% rayon, about 25% polypropylene and about 6% cotton and having a basis weight of about 75 g / m2 available from Veratec, Inc. Walpole, MA; NovonetR 149-191, a thermo bonded grid-like material containing about 69% rayon, about 25% polypropylene and about 6% cotton and having a basis weight of about 100g / m2, available from Veratec, Inc. MA; HEF Nubtex® 149-801, an embossed material with hydroentangling aperture containing approximately 100% polyester and having a weight of approximately 70m / g2, available from Veratec, Inc. Waipole, MA, KeybakR 951V, a dry material formed with aperture containing about 75% rayon, about 25% acrylic fibers and having a basis weight of about 43m / g2, available from Chicopee; New Brunswick, NJ; KeybakR 1236, an apertured material, containing approximately 75% rayon, approximately 25% polyester and having a basis weight of approximately 39m / g2 available from Chicopee, New Brunswick, NJ; DuralaceR 1236, a material with hydroentanglement opening containing
approximately 100% rayon and having a basis weight of about 40m / g2 to about 115m / g2, available from Chicopee,
New Brunswick, NJ; DuralaceR 5904; a hydroentangling aperture material containing approximately 100% polyester and having a basis weight of about 40m / g2 to about 115m / g2 available from Chicopee, New Brunswick, NJ; Sontaro 8868, a hydroentangling material containing approximately 50% cellulose and around 50% polyester and having a basis weight of about
60m / g2 available from Dupont Chemical Corp. Alternatively, the water insoluble substrate may be a polymeric mesh sponge as described in European Patent Number EP 702550 A1 published March 27, 1996, incorporated by reference herein in its entirety. The polymeric sponge includes a plurality of layers of an extruded tubular netting prepared from strong flexible polymer, such as polymers of monomer addition and polyolefin polyamide of polycarboxylic acids. Although these polymeric sponges are designed to be used in conjunction with a liquid cleaner, these types of sponges can be used as the water insoluble substrate in the present invention. The substrate can be made in a wide variety of shapes and figures including flat pads, thick pads, thin sheets, products in the shape of balls, products with irregular shapes and having sizes that have a scale of a surface area of
approximately 6.45cms2 to around hundreds of square centimeters. The exact size will depend on the desired use and the characteristics of the product. Especially convenient are square, circular, rectangular or oval pads having a surface area of about 6.45cm2 to about 929cm2, preferably about 65cm2 to about 774cm2, and more preferably about 194cm2 to about 516cm2 and a thickness of about 25.4 At about 12,700 microns, preferably from about 127 microns to about 6350 microns and more preferably from about 254 microns to about 2,540 microns. The water-insoluble substrates in the present invention may include two or more layers, each having different textures and abrasiveness. Different textures can result from different combinations of materials or from the use of different manufacturing processes or a combination thereof. A double-texture substrate can be made by providing the advantage of having a more abrasive side for exfoliation and a softer, absorbent side for gentle cleaning. In addition, the separate layers of the substrate can be manufactured to have different colors, so it will help the user to further distinguish the surfaces.
SPURIOUS SURGICAL AGENT
The products of the present invention include from about 0.5% to about 12.5%, preferably from about 0.75% to
about 11% and more preferably from about 1% to about 10%, based on the weight of water-insoluble substrate, of a foaming surfactant. By means of a foaming surfactant means a surfactant, which when combined with water and mechanically stirred generates a foam or suds. Preferably, these surfactants or combinations of surfactants should be soft, which means that these surfactants provide sufficient detersive cleaning or benefit, but do not dry the skin or hair too much and still meet the foaming criteria described above. A wide variety of foaming surfactants are useful herein and include those selected from the group consisting of anionic foaming surfactants, nonionic foaming surfactants, amphoteric foaming surfactants, and mixtures thereof. The cationic surfactants can be used as optional components, provided that they do not negatively impart the total foaming characteristics of the required foaming surfactants.
AGENTS TENSIOACTIVQS ANIQNICQS ESPUMANTES
Non-limiting examples of anionic foaming surfactants useful in the compositions of the present invention are described in McCutcheon's, Detergents and Emulsifiers, North American edition (1986),
published by Publishipg Corporation; McCutcheon's, Functional Materials, North Amepcan Edition (1992); and U.S. Patent No. 3,929,678 to Laughlin et al., issued December 30, 1975, which are hereby incorporated by reference in their entirety. A wide variety of foaming anionic surfactants is useful here. Non-limiting examples of anionic foaming surfactants include those selected from the group consisting of sarcosinates, sulfates, isethionates, taurates, phosphates and mixtures thereof. Among the isethionates, the alkylisethionates are preferred and among the sulphates, the alkyl ether sulphates and alkyls are preferred. Typically, the alkylisisationates have the formula RCO-OCH2CH2SO3M wherein R is alkyl or alkenium from about 10 to about 30 carbon atoms and M is a water-soluble cation such as ammonium, sodium, potassium and triethanolamine. Non-limiting examples of these isethionates include the alkylisethylethates selected from the group consisting of ammonium cocoyl isethionate, sodium cocoyliseionate, sodium lauroyl isethionate and mixture thereof. Alkyl sulfates and ether sulfates typically have the respective formulas ROS3M and RO (C2H4?) XS03M, wherein R is alkyl or alkenyl of about 10 carbon atoms, x is from about 1 to about 10 and M is a cation soluble in water such as ammonium, sodium, potassium and triethanolamine. Another suitable class of anionic surfactants is water-soluble salts of organic reaction products, of sulfuric acid of the general formula:
1- SO 3 - M wherein R 1 is selected from the group consisting of a straight or branched chain saturated aliphatic hydrocarbon radical having from about 8 to about 24, preferably from about 10 to about 16 carbon atoms; and M is a cation. Still other synthetic anionic surfactants include the class designated as succinamates, olefin sulphonates having from about 12 to about 24 carbon atoms, and b-alkyoxyalkanesulfonates. Examples of these materials are sodium laurisulfate and ammonium laurisulfate. Other anionic materials include sarcosinates, non-limiting examples including sodium lauryl sarcosinate, sodium cocoyl sarcosinate, and ammonium lauryl sarcosinate. Other anionic materials useful herein are soaps (e.g., alkali metal salts, e.g., sodium or potassium salts) or fatty acids, typically having from about 8 to about 24 carbon atoms, preferably from about 10 to about 20 carbon atoms. The fatty acids used in making the soaps can be obtained from natural sources such as, for example, glycerides derived from plants or animals (for example, palm oil, coconut oil, soybean oil, castor oil, tallow, lard, etc.). Fatty acids can also be prepared synthetically. The soaps are described in more detail in U.S. Pat. No. 4,557,853, cited above.
Other anionic materials include phosphates such as monoalkium, dialkyl and trialkyl phosphate salts. Other anionic materials include alkanoylsarcosinates corresponding to the formula RCON (CH3) CH2CH2C? 2M, wherein R is alkyl or alkenyl of about 10 to about 20 carbon atoms, and M is a water soluble cation such as ammonium, sodium, potassium and trialkanolamine (for example, triethanolamine), a preferred example thereof is sodium lauryl sarcosinate. Taurates that are based on taurine, which is also known as 2-aminoethanesulfonic acid, are also useful. Examples of taurates include N-alkyltauphines such as the preparation by reacting dodecylamine with sodium isethionate in accordance with what is taught in the U.S. patent.
No. 2,658,072 which is incorporated herein by reference in its entirety. Non-limiting examples of preferred foaming anionic surfactants useful herein include those selected from the group consisting of sodium laurisulfate, ammonium lauryl sulfate, ammonium lauryl sulfate, sodium lauryl sulfate, sodium tridice-sulfate, ammonium cetyl sulfate, sodium cetyl sulfate, cocoyl isethionate. of ammonium, sodium lauroyl isethionate, laurollsarcosinate sodium and mixtures thereof. Especially preferred for use herein are ammonium lauryl sulfate and ammonium laureth sulfate.
THICKNESS NON-IONIC SURGICAL AGENTS
Non-limiting examples of foaming nonionic surfactants for use in the compositions of the present invention are described in McCutcheon's, Detergents and Emulsifiers, North American edition (1986), published by Publishing Corporation; and McCutcheon's, Functional Materials, North American Edition (1992); which are incorporated by reference herein in their entirety. Nonionic foaming surfactants useful herein include those selected from the group consisting of alkyl glycosides, aiquilpolyglucosides, polyhydroxy fatty acid amides, alkoxylated fatty acid esters, sucrose esters, amine oxides, and mixtures thereof. Alkyl glucosides and alkyl polyglucosides are useful herein and can be broadly defined as condensation products of long chain alcohols, for example, C8-30 alcohols with sugars or starches or sugar or starch polymers, for example glycosides or polyglycosides. These compounds can be represented by the formula (S) n-0-R wherein S is a sugar portion such as glucose, fructose, mannose and galactose; n is an integer from about 1 to about 1000, and R is an alkyl group of C8-30. Examples of long chain alcohols from which the alkyl group may be derived include decyl alcohol, cetyl alcohol, stearyl alcohol, lauryl alcohol, myristyl alcohol, oleyl alcohol, and the like. Preferred examples of these surfactants include in
those S is a glucose portion, R is an alkyl group of C8-20, and n is an integer from about 1 to about 9. Commercially available examples of these surfactants include decyl polyglucoside (available as APG 325 CS from Henkel) and lauplpollglucosida (available as APG 600CS and 625 CS from Henkel). Also useful are sucrose ester surfactants such as sucrose cocoate and sucrose laurate. Other useful nonionic surfactants include polyhydroxy fatty acid amide surfactants, more specific examples of which includes glucosamides, corresponds to the structural formula:
or R 1 R 22 C 1 I wherein R 1 is H, C 1 -C 4 alkyl. 2-hydroxyethyl, 2-hydroxypropyl, preferably C 1 -C 4 alkyl, more preferably methyl or ethyl, more preferably still methyl; R2 is C5-C31 alkyl or alkenyl, preferably C7-C19 alkyl or alkenyl, more preferably C9-C17 alkyl or alkenyl, more preferably still Cn-C5 alkyl or alkenyl; and Z is a polyhydroxyhydrocarbyl moiety having a linear hydrocarbyl chain with at least 3 hydroxyls directly connected to the chain or an alkoxylated derivative (preferably ethoxylated or propoxylated) thereof: Z preferably is a sugar portion selected from the group consisting of glucose, fructose, maltose, lactose, galactose, mannose, xylose and
mixtures thereof. An especially preferred surfactant corresponding to the structure mentioned above is cocoalkyl N-methylglucosidamide (for example, wherein the R2CO- portion is derived from fatty acid and coconut oil). Methods for making compositions containing polyhydroxy fatty acid amide are described, for example, in Great Britain Patent Specification 809,060, published February 18, 1959 by Thomas Hedley & Co., Ltd .; patent of E.U.A. No. 2,965,576, by E.R. Wilson, issued December 20, 1960; patent of E.U.A. No. 2,703,798, by A.M. Schwartz, issued on March 8, 1955 and patent of E.U.A. No. 1, 985,424 of Piggott, issued on December 25, 1934; which are incorporated herein by reference in their entirety. Other examples of nonionic surfactants include amine oxides. The amine oxides correspond to the general formula of R.R2R3NO, wherein R1 contains an alkyl, alkenyl or monohydroxyalkyl radical of from about 8 to about 18 carbon atoms from 0 to about 10 portions of ethylene oxide and from 0 to about 1 glyceryl moiety, and R2 and R3 contain from about 1 to about 3 carbon atoms and from 0 to about a hydroxy group, for example methyl, ethyl, propyl, hydroxyethyl or hydroxypropyl radicals. The arrow in the formula is a conventional representation of a semipolar linker. Examples of amine oxides suitable for use in this invention include dimethyl dodecylamine oxide, oleyl di (2-hydroxyethyl) amine oxide, dimethyloctylamine oxide,
dimethyl-decylamine oxide, dimethy-tetradecylamine oxide, 3,6,9-trioxaheptadecyldietylamine oxide, di (2-hydroxyethyl) -tetradecylamine oxide, 2-dodecox? ethyldimethylamine oxide, 3-dodecoxy-2-oxide hydroxypropyl (3-hydroxypropyl) amine, dimethylhexadecylamine oxide. Non-limiting examples of preferred nonionic surfactants for use herein are those selected from the group consisting of C8-C14 glucosamides, C8-C14 alkyl polyglycosides, sucrose cocoate, sucrose laurate, lauramine oxide, cocoamine oxide and mixtures thereof.
SEQUENTIAL ANTI-THERAPY TENSITIVE AGENTS The term "amphoteric foaming surfactant" as used herein is also intended to encompass zwitterionic surfactants, which are well known to formulators skilled in the art as a subset of amphoteric surfactants. A wide variety of amphoteric foaming surfactants can be used in the compositions of the present invention. Particularly useful are those which are broadly described as derivatives of secondary and tertiary aliphatic amines, preferably wherein the nitrogen is in a cationic state, wherein the aiiphatic radicals can be straight or branched chains and wherein one of the radicals contains a group soluble in ionizable water, for example, carboxy, sulfonate, sulfate, phosphate or phosphonate.
Non-limiting examples of amphoteric surfactants useful in the composition of the present invention are described in
McCutcheon's, Deterqents and Emulsifiers. North American edition (1986), published by Publishing Corporation; and McCutcheon's, Functionai Materials. North American Edition (1992); which are incorporated by reference herein in their entirety. Non-limiting examples of amphoteric or zwitterionic surfactants are those selected from the group consisting of betaines, sultaines, hydroxysultaines, alkyliminoacetates, iminodialkanoates, aminoalkanoates and mixtures thereof. Examples of betalnes include higher alkylbetaines, such as cocodimethylcarboxymethylbetaine, laurodimethylcarboxymethylbetaine lauryldimethylalphacarboxyethylbetaine, cetyldimethylcaroboxymethylbetaine, cetyl dimethylbetaine (available as Lonzaine 16SP from Lonza Corp.), lauryl bis- (2-hydroxyethyl) carboxymethbetaine, oleyldimethylgamma-caroxlpropylbetaine, lauryl bis- (2- hydroxypropyl) alpha-carboxyethetataine, cocodimetiisulfopropylbetaine, lauryldimethylsufoetylbetaine, lauryl bis- (2-hydroxyethyl) sulfopropylbetaine, amidobetaine and amidosulfobetaines (wherein the radical RCOHN (CH) 3 is attached to the nitrogen atom of betaine), oleylbetaine ( available as Velvetex OLB-50 amphoteric from Henkel) and cocamidopropylbetaine (available as Velvetex BK-35 and BA-35 from Henkel).
Examples of sultaines and hydroxysultaines Include materials such as cocamidopropylhydroxysultaine (available as Mirataine CBS from Rhone-Poulenc). Preferred amphoteric surfactants for use herein have the following structure:
or R 2 R 1 (C NH (CH 2m) fl + N fí-x L wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain having from about 9 to about 22 carbon atoms Preferred R1 has from about 11 to about 18 carbon atoms, more preferably from about 12 about 18 carbon atoms, more preferably from about 14 to about 18 carbon atoms, m is an integer from about 1 to about 3, more preferably from about 2 to about 3 and more preferably about 3; n is 0 or 1, preferably 1; R2 and R3 are independently selected from the group consisting of alkyl having from 1 to about 3 carbon atoms, unsubstituted or monosubstituted with hydroxy, preferred R2 and R3 are CH3; X is selected from the group consisting of the group consisting of C02, S03 and S0; R4 is selected from the group consisting of saturated or unsaturated alkyl do, direct or branched chain, no
substituted or moposubstituted with hydroxy, having from 1 to about 5 carbon atoms. When X is C0, R4 preferably has 1 or 3 carbon atoms, more preferably 1 carbon atom. When X is S03 or SO4, R4 preferably has from about 2 to about 4 carbon atoms, more preferably 3 carbon atoms. Examples of amphoteric surfactants of the present invention include the following compounds: Cetyldimethylbetaine (this material also has the designation cetylbetaine CTFA)
CH, c 16C33 + N CH2 C02"
Cocamidopropylbetaine
wherein R has from about 9 to about 13 carbon atoms.
Cocamidopropylhydroxysultaine
R- C-NH- (CH 2) 3 -N-CH 2 -CH-CH 2 --0 3 CH 3 wherein R has from about 9 to about 13 carbon atoms. Examples of other useful apotheric surfactants are alkyliminoacetates and iminodyalkanoates and aminoalkanoates of formulas RN [(CH2) mC? 2] 2 and RNH (CH2) mC02M, wherein m is from 1 to 4, R is an alkyl or alkenyl of C8- C22, and M is H, alkali metal, ammonium alkali metal, alkanolammonium. Also, imidazolinium and ammonium derivatives are included. Specific examples of suitable amphoteric surfactants include sodium 3-dodecyl-aminopropionate, sodium 3-5-dodecylaminopropansulfonate, higher N-alkyl aspartic acids as produced in accordance with what is taught in the US patent. 2,438,091 which is incorporated herein by reference in its entirety; and the products sold under the trade name "Miranol" and described in US patent. 2,528,378, which is incorporated herein by reference in its entirety. Other examples of useful amphoteric include amphoteric phosphates, such as chloride-phosphate coamidopropyl PG-dimonium (commercially available as Monaquat PTC, from Mona Corp.). As well
useful are amphoacetates such as disodium lauroamphodiacetate, sodium lauroamphoacetate and mixtures thereof. Preferred for use herein foaming surfactants are the following, wherein the foaming anionic surfactant is selected from the group consisting of lauroyl sarcosinate, ammonium tridecetsulfato sodium luroilsarcosipato sodium laureth ammonium laureth sodium lauriisulfato of ammonium lauriisulfato sodium, ammonium cocoyl isethionate, sodium cocoilisetlonato lauroyl sodium lauroillsetionato sodium, sodium cetyl sulphate and mixtures thereof; wherein the foaming surfactant is selected not onium the group consisting of lauramine oxide, cocoamine oxide, decyl polyglucose, laurilpoliglucosa, sucrose cocoate, C12-14 glucosamides of laurate, sucrose and mixtures thereof; and wherein the amphoteric lathering surfactant is selected from the group consisting of disodium lauroamphodiacetate, sodium lauroamphoacetate, cetlldimetilbetaína cocoamidopropylbetain, cocoamidopropyl, and mixtures thereof.
CONDITIONER COMPONENT
The products of the present invention include an oil-soluble conditioning agent that is useful for providing a conditioning benefit to the skin or hair during use of the product. The agent
oil-soluble conditioner includes about 1% about 99%, preferably about 2% about 50% and more preferably about 3% about 25% by weight of said water-insoluble substrate. The oil-soluble conditioning oil is selected from one or more soluble conditioning agents, whereby the heavy arithmetic average solubility parameter of the oil-soluble conditioning agent is less than or equal to 10.5. It is recognized, based on the mathematical definition of solubility parameters, that it is possible, for example, obtain the parameter arithmetic mean solubility heavy required, for example, less than or equal to 10.5, for an agent soluble conditioning oil including two or more compounds, if one of the compounds has an individual solubility parameter greater than 10.5. Solubility parameters are well known in formulation chemistry for those skilled in the art and are routinely used as a guide for the compatibility and solubilities of materials in the formulation process. The solubility parameter of a chemical compound, d, is defined as the square root of the cohesive energy density for that compound. Typically, a solubility parameter for a compound is calculated from tabulated values of the contributions of the additive group for the heat of vaporization and the molar volume of the components of that compound, using the following equation:
where S, S, the sum of the heat of vaporization of the additive group contpbuciones, and S, m, the sum of the contributions of the additive group of molar volume. Standard vaporization heat tabs and molar volume additive group contributions for a wide variety of atoms and groups of atoms are collected in Barton, A.F.M. Handbook of Solubilitv Parameters. CRC Press, Chapter 6, Table 3. Pp. 64-66 (1985), which is unofficial here by reference in its entirety. The equation above solubility parameter is described in Fedors, R.F., "A Method for Estimating Both the Solubility Parameters and Molar Volumes of Liquids", Polvmer Ep ineerinq and Science, vol. 14, no. 2, pp. 147-154 (February 1974), which is hereby incorporated by reference in its entirety. The solubility parameters obey the laws of mixtures, so the solubility parameter for a mixture of materials is given by the heavy arithmetic medium (for example, the heavy average) of
the solubility parameters for each component of that mixture. See, Handbook of Chemistrv and Phvsiscs. 57 edition, CRC Press, p. C-726 (1976-1977), which is hereby incorporated by reference in its entirety. The formulation chemicals typically report and use solubility parameters in units of (cal / cm3) 1'2. The tabulated values of contributions of additive groups for heat of vaporization in Handbook of Solubilitv Parameters are reported in units of Kj / mol. However, this tabulated heat of vaporization values is easily converted to cal / ml using the following well-known relationships:
1 J / mol = 0.239006 cal / mol and 1000 J = 1 Kj.
See Gordon, A.J. et al., The Chemist's Companion, John Wiley & Sons, pp. 456-463. (1972), which is hereby incorporated by reference in its entirety. The solubility parameters have also been tabulated for a wide variety of chemical materials. Solubility parameter tabulations are found in the aforementioned Handbook of Solubilitv Parameters. Also see "Solubility Effects In Product, Package, Penetration, And Preservation," C.D. Vaughan, Cosmetics and Toiletries. vol. 103, October 1988, pp. 47-69, which is incorporated herein by reference in its entirety.
Non-limiting examples of conditioning agents useful as oil-soluble conditioning agents include those selected from the group consisting of mineral oil, petrolatum, branched chain hydrocarbons of C7-C40, esters of C1-C30 alcohol of C1-C30 carboxylic acids, esters of C1-C30 alcohol of dicarboxylic acids of C1-C30, monoglycerides of carboxylic acids of C1-C30, diglycerides of carboxylic acids of C1-C30, triglycerides of carboxylic acids of C1-C30, monoesters of ethylene glycol of carboxylic acids of C1-C30 , ethylene glycol diesters of C 1 -C 30 carboxylic acids, propylene glycol monoesters of C 1 -C 30 carboxylic acids, propylene glycol diesters of C 1 -C 30 carboxylic acids, monoesters and polyesters of C 1 -C 30 carboxylic acid sugars, polydialkylsiloxanes, polydiarylysiloxanes , polyalcarbylsiloxanes, cyclometicopes that have from 3 to 9 silicone atoms, vegetable oils, veg oils esters, hydrogenated vegetable oils, polypropylene glycol of C4-C20 alkyl ethers, C8-C30 alkyl diets and mixtures thereof. Mineral oil, which is also known as petrolatum liquid, is a mixture of liquid hydrocarbons obtained from petroleum. See The Merck Index, tenth edition, Entry 7048, p. 1033 (1983) and International Cosmetic Ingredient Dictíonary, 5th Edition vol. 1 p. 415-417 (1993), which are hereby incorporated by reference in their entirety. Petrolatum, which is also known as petroleum jelly, is a colloidal system of non-direct chain solid hydrocarbons.
high boiling liquid hydrocarbons, in which the majority of liquid hydrocarbons are kept inside micelles. See The Merck
Index, tenth edition, Entry 7047, p. 1033 (1983); Schindler, Dr Cosmet.
Ind "89, 36-37, 76, 78-80, 82 (1961); and International Cosmetic Ingredient Dictionary, 5th Edition, vol. 1 p. 537 (1993), which are hereby incorporated by reference in their entirety. Straight and branched chain hydrocarbons having from about 7 to about 40 carbon atoms are useful herein. Non-limiting examples of these hydrocarbon materials include dodecane, isododecane, squalene, cholesterol, polyisobutylene, docosane (e.g., C22 hydrocarbon), hexadecane, isohexadecane (a commercially available hydrocarbon sold as Permethyl R 101A from Presperse, South Plainfield, NJ). Also useful are C7-C40 soparaffins, which are branched C7-C40 hydrocarbons. Also useful are the C 1 -C 30 alcohol esters of carboxylic acids of C 1 -C 30 carboxylic acids and C 2 -C 30 dicarboxylic acids, including direct or branched chain materials, as well as aromatic derivatives. Also useful are esters such as monoglycerides of carboxylic acids of C1-C30, diglycerides of carboxylic acids of C1-C30, triglycerides of carboxylic acids of C1-C30, monoesters of ethanol glycol of carboxylic acids of C1-C30, diesters of ethylene glycol of carboxylic acids of C1-C30, monoesters of propylene glycol of carboxylic acids of C1-C30 and diesters of propylene glycol of carboxylic acids of C1-C30. The acids
either straight or branched chain carboxylic acids are also included here.
The propoxylated and ethoxylated derivatives of these materials are also useful. Non-limiting examples include diisopropylsebacate, Dlisopropiladipato, sopropilmiristato, isopropyl palmitate, miristilpropionato, etilenglicoldistearato, 2-ethylhex? Lpalmitato, sodecilneopentanoato, di-2-etilhexilmaleato, cetyipalmitato, miristilmiristato, esteariiestearato, cetilestearato, behenilbehenrato, dioctyl, dioctyl sebacate, diisopropyl adipate, cetiloctanoato, diisopropildilinoleato, caprylic / capric, caprylic / capric PEG-6, triglyceride, caprylic / capric PEG-8; and mixtures thereof. Also useful are various C 1 -C 30 monoesters and polyesters of sugars and related materials. These esters are derived from a sugar or polyol portion and one or more carboxylic acid moieties. Depending on the constituent acid and sugar, the esters may be in liquid or solid form at room temperature. Examples of liquid esters include: glucose tetraoleate, glucose tetraesters, glucose tetraesters of soybean oil fatty acids (unsaturated), mixed soybean oil fatty acid tetraesters, galactose tetraesters of oleic acid, tetraesters of linoleic acid arabica, xylose tetralinoleate, galactose pentaoleate, sorbitol tetraoleate, sorbltol hexaesters of unsaturated soybean oil fatty acids, xylitol pentaoleate, sucrose tetraoleate, sucrose pentaolate, sucrose hexaoleate, sucrose heptaleate, sucrose octaoleate and
mixtures thereof. Examples of solid esters include: sorbitol hexaester in which the carboxylic acid ester portions are palimotoleate and arachididate in a molar ratio of 1: 2; the octaester of raffinose in which the carboxylic acid ester portions are linoleate and behenate in a molar ratio of 1: 3; the maltose heptaester wherein the esterifying carboxylic acid moieties are lignocerate sunflower seed oil fatty acids in a molar ratio of 3: 4; the octaester of sucrose wherein the esterifying carboxylic acid moieties are oleate and behenate in a molar ratio of 2: 6; and the octaester of sucrose wherein the esterifying carboxylic acid moieties are laurate, linoleate and behenate in a molar ratio of 1: 3: 4. A preferred solid material is sucrose polyester in which the degree of sterilization is 7-8, and in which the fatty acid portions with mono- and / or di-unsaturated and behenyl C18, in a molar ratio of not saturated: behenic from 1: 7 to 3: 5. A preferred solid sugar polyester is the sucrose octaester in which there are 7 behenic fatty acid portions and about one portion of oleic acid in the molecule. Other materials include cottonseed oil or fatty acid esters of sucrose soybean oil . Ester materials are further described in U.S. Patent No. 2,831, 854, U.S. Patent 4,005,196, Jandacek, issued January 25, 1977; U.S. Patent No. 4,005,195, to Jandacek, issued January 25, 977, U.S. Patent No. 5,306,516 to Letton and others,
issued on April 26, 1994; U.S. Patent No. 5,306,515 to Letton et al., Issued April 26, 1994; U.S. Patent No. 5,305,514 to Letton et al., Issued April 26, 1994;
U.S. Patent No. 4,797,300 to Jandacek et al., Issued on Jan. 10, 1989; U.S. Patent No. 3,963,699 to Rizzi et al., Issued June 15, 1976; U.S. Patent No. 4,518,772 to Volpenhein, issued May 21, 1985; and U.S. Patent No. 4,517,360 to Volpenhein, issued May 21, 1985; which are incorporated herein by reference in their entirety. Non-volatile silicones such as polydialkylsiloxanes, polydiarylsiloxanes, and polyalkarylsiloxanes are also useful oils. These silicones are described in U.S. Patent No. 5,069,897 to Orr, issued December 3, 1991, which is incorporated herein by reference in its entirety. The polyalkylisiloxanes correspond to the general chemical formula R3S0O [R2SiO] xSiR3 wherein R is an alkyl group (preferably R is methyl or ethyl, more preferably methyl) and x is an integer of up to about 500, chosen to achieve the desired molecular weight . Commercially available polyalkyl siloxanes include the polydimethylsiloxanes, which are also known as dimethicones, non-limiting examples thereof include the Vicasil® series sold by the General Electric Company and the Dow Corning® 200 series sold by Dow Corning Corporation. Specific examples of polydimethylsiloxanes that are used herein include Dow Corning® 225 fluid having a viscosity of 10 centistokes
and a boiling point greater than 200 ° C, and Dow Corning® 200 fluids having viscosities of 50, 350 and 12,500 centistokes, respectively and boiling points greater than 200 ° C. Also useful are materials such as trimethylsiloxysilicate, which is a polymeric material that corresponds to the general chemical formula [(CH2) 3SiO? 2] x [Si? 2], where x is an integer from about 1 to about 500 ey is an integer from about 1 to about 500. A commercially available trimethylsiloxysilicate is sold as a mixture with dimethicone as Dow Corning®593 fluid . Also useful here are the dimethiconols, which are hydroxyl terminated in dimethylsilicon. These materials can be represented by the general chemical formulas R3SiO [R2SiO]? SiR2OH and HOR2S00 [R2SiO] xS¡R2OH, wherein R is an alkyl group (preferably R is methyl or ethyl, more preferably methyl) and x is an integer of about 500, chosen to achieve the desired molecular weight. Commercially available dimethiconols are typically sold as mixtures such as dimeticon or cyclomethicon (eg Dow Corning® 1401, 1402, and 1403 fluids). Also useful herein are polyalkylarylsiloxanes, with polymethylphenylsiloxabs having viscosities of about 15 about 65 centrlsokes at 25 ° C are preferred. These materials are available, for example, as SF 1075 methylphenyl fluid (sold by General Electric Company) and feniltrimeticon 556 Cosmetic Grade fluid (sold by Dow Corning Company). Vegetable oils and hydrogenated vegetable oils are also useful here. Examples of vegetable oils and vegetable oils
hydrogenated include safflower oil, castor oil, coconut oil, cottonseed oil, shad oil, palm kernel oil, palm oil, peanut oil, soybean oil, colaza oil, flaxseed oil, rice bran oil, pine oil, sesame oil, sunflower seed oil, hydrogenated sunflower oil, hydrogenated castor oil, hydrogenated coconut oil, hydrogenated cottonseed oil, hydrogenated bran oil, grain oil Hydrogenated Palm Oil, Hydrogenated Palm Oil, Hydrogenated Peanut Oil, Hydrogenated Soybean Oil, Hydrogenated Soybean Oil, Hydrogenated Colase Oil, Hydrogenated Flaxseed Oil, Hydrogenated Rice Bran Oil, Hydrogenated Sesame Seed Oil, Hydrogenated Seed Oil hydrogenated sunflower and mixtures thereof. Also useful herein are the C4-C20 alkyl ethers of polypropylene glycols, C1-C20 carboxylic acid esters of polypropylene glycols and C8-C30 dialkyl ethers. Non-limiting examples of its materials include butyl ether PPG-14, stearyl ether of PPG-15, dioctyl ether, dodecyl octyl ether and mixtures thereof.
WEIGHT RELATIONS AND WEIGHT PERCENTAGES
In the present invention, the weight ratio of the foaming surfactant to the oil soluble conditioning agent is less than about 20: 1, preferably less than about
: 1, preferable less than 5: 1, and more preferably less than about 2: 1. In certain embodiments of the present invention, the cleaning and conditioning component, which is defined, since it includes a foaming surfactant and an oil-soluble conditioning agent, the foaming surfactant includes from about 1% about 75%, preferably about 10%. % to about 65%, more preferably from about 15% to about 45% by weight of the cleaning and conditioning component, and the oil-soluble conditioning agent including about 5% about 99%, preferably about 7.5% about 50% and more preferably about 10% about 30% by weight of the cleaning and conditioning component.
ADDITIONAL INGREDIENTS
The products of the present invention may include a wide variety of optional ingredients. Some of those ingredients are listed in more detail in the present. Particularly useful are several useful active ingredients to provide various benefits to the skin or hair during cleaning and conditioning procedures. In these compositions, the product is useful for delivering the active ingredient to the skin or hair.
ACTIVE INGREDIENTS
The compositions of the present invention may include a safe and effective amount of one or more active ingredients or pharmaceutically acceptable salts thereof. The term "safe and effective amount" as used herein, means an amount of an active ingredient high enough to modify the condition to be treated or to provide the desired benefit to the skin, but low enough to avoid serious effects secondary in a reasonable benefit to the risk ratio within the scope of the medical probing trial. What is a safe and effective amount of active ingredient will vary with the specific active ingredient, the ability of the active ingredient to penetrate through the skin, the age, health condition and condition of the user's skin and other similar factors.
The active ingredients useful herein can be categorized by their therapeutic benefit and their postulated mode of action. However, it should be understood that the active ingredients useful herein may, in some instances provide more than one therapeutic benefit or operate by more than one mode of action. Therefore, the classifications herein are made for the sake of convenience and do not pre-dilute the active ingredient to a particular application or applications listed. Also, the pharmaceutically acceptable salts of these ingredients
assets are useful in the present. The following active ingredients are useful in the compositions of the present invention. Active anti-acne ingredients: Examples of active anti-acne ingredients include keratolytics such as salicylic acid (o-hydroxybenzoic acid), salicylic acid derivatives such as 5-octane salicylic acid and resorcinol, retinoids such as retinoic acid and its derivatives (eg, cis and trans); amino acids containing sulfur D and L and their derivatives and salts, particularly their N-acetyl derivatives, a preferred example thereof is N-acetyl-L-cysteine; lipoic acid; antibiotics and antimicrobials such as benzoyl peroxide, octopirox, tetracycline, 2, 4, 4'-trichloro-2'-hydroxy diphenyl alcohol, 3,4'-trichlorobanilium, azelaic acid and its derivatives, phenoxyethanol, phenoxypropanol, phenoxyisopropanol, acetate of ethyl, clindamycin and meclocycline; sebostats such as flavonoids; and bile salts such as scimolsulfate and its derivatives, deoxycholate and cholate. Active ingredients for anti-arruaas and anti-antrophy of the skin: Examples of active ingredients for anti-wrinkles and antiantrofia of the skin include retinoic acid and its derivatives (for example, cis and trans); retinol; retinyl esters; niacinamide; salicylic acid and derivatives thereof, amino acids D and L containing sulfur and its derivatives and salts, particularly the N-acetyl derivatives, a preferred example of which is N-acetyl-L-cysteine; thiols, for example, etantiol; hydroxy acid, phytic acid, lipoic acid; lysophosphatidic acid and skin peeling agents (eg, phenol and the like).
Non-steroidal anti-inflammatory active ingredients fNSAIDS: Examples of NSAIDS include the following categories derived from propionic acid; acetic acid derivatives; phenamic acid derivatives; biphenylcarboxylic acid derivatives; and oxicamas. All these NSAIDS are described
completely in United States Patent 4,895,459 to Sunshine et al., Issued January 15, 1991 incorporated herein by reference in its entirety. Examples of useful NSAIDS include acetylsalicylic acid, ibuprofen, naproxen, benoxaprofen, flurbiprofen, fenoprofen, fenbufen, ketoprofen, indoprofen, piprofen, carprofen, oxaprozin, pranoprofen, or microprofen, thioxaprofen, suprofen, alminoprofen, thiaprofenic acid, fluprofen and bucilloxic acid. Also useful are only steroidal anti-inflammatory drugs including hydrocortisone and the like. Topical Anesthetics: Examples of topical anesthetic drugs include benzocaine, lidocaine, bupivacaine, chlorprocaine, dibucaine, etidocaine, mepivacaine, tetracaine, diclonine, hexylcaine, procaine, cocaine, ketamine, pramoxin, phenol, and pharmaceutically acceptable salts thereof. Artificial tanning agents and accelerators: Examples of artificial tanning agents and accelerators include dihydroxyacetaone, tyrosine, tyrosine esters such as ethyl tyrosinate and phospho-DOPA. o Antimicrobial and antifungal active ingredients: Examples of antimicrobial and antifungal active ingredients include ß-lactam drugs, qulnolone drugs, ciprofloxacin, norfioxacin, tetracycline, erythromycin, amikacin, 2,4,4'-trichloro-2'-hydroxydifen licco, 3,4,4'-trichlorobanilido, phenoxyethanol,
phenoxypropanol, phenoxy-isopropanol, doxycycline, capreomycin, chlorhexidine, chlortetracycline, oxytetracycline, clidamycin, ethambutol, hexamidine isethionate, metronidazole, pentamidine, gentamcin, kanamycin, iiomycin, methacycline, methenamine, minocycline, neomycin, netilmicin, paromonicin, streptomycin, tobramycin, miconazole, hydrochloride of tetracycline, erythromycin, zinc erythromycin, erythromycin estolate, erythromycin stearate, amicacinsulfate, doxycycline hydrochloride, capreomycin sulfate, chlorhexidingluconate, chlorhexidine hydrochloride, chlortetracycline hydrochloride, oxytetracycline hydrochloride, clindamycin hydrochloride, ethambutol hydrochloride, metronizadol hydrochloride, pentamidine hydrochloride, gentamicinsulfate, kanamylin sulfate, lineomicipa hydrochloride, metacycline hydrochloride, methenaminhipurate, methenaminmandelate, minocycline hydrochloride, neomycin sulfate, netilmicin sulfate, paromomycin sulfate, streptomycin sulfate, tobramycin sulfate, miconazole hydrochloride, amanfadine hydrochloride, amanfadinsulfate, octopirox, paracioromethylenol, nystatin , tolnaftate, zinc pyrithione and clotrimazole. Preferred examples of various useful actives herein include those selected from the group consisting of salicylic acid, benzoyl peroxide, 3-hydroxybenzoic acid, lactic acid, 4-hydroxybenzoic acid, acetylsalicylic acid, 2-hydroxybutanoic acid, 2-hydroxypentanoic acid, -hydroxyhexanoic, cis-retinoic acid, trans-retinic acid, retinol, phytic acid, N-acetyl-L-cysteine, lipoic acid, azelaic acid, arachidonic acid, benzoyl peroxide, tetracycline, ibuprofen, naproxen,
hydrocortisone, acetominophen, resorcinol, phenoxyethanol, phenoxypropanol, phenoxyisoproranol, 2, 4, 4'-trichloro-2'-hydroxydipenilic acid, 3,4'-trichlorocarbanilide, octopirox, lidocaine hydrochloride, clotrimazole, micronazole, neocicin sulfate and mixture of the same. Active ingredients of sunscreen: Also useful here are the active ingredients of sunscreen. A wide variety of active sunscreen agents are described in U.S. Patent No. 5,087,445 to Haffey et al., Issued February 11, 1992; U.S. Patent No. 5,073,372 to Tumer et al., Issued December 17, 1991; U.S. Patent No. 5,073,371 to Tumer et al., Issued December 17, 1991; and Segarin et al., in Chapter VIII, page 189 et seq, of Cosmetics Sciences v Technoloov: which are hereby incorporated by reference in their entirety. Non-limiting examples of sunscreens that are useful in the compositions of the present invention are selected from the group consisting of 2-ethylhexyl p-methoxycinnamate, 2-ethylhexyl N, N, -dlmethyl-p-aminobenzoate, p-aminobenzoic acid, 2- acid Phenylbenzimidazole-5-sulfonic acid, octocrylene, oxybenzone, homomethylsalicylate, octylsalicylate, 4,4'-methoxy-t-butyldibenzoylmethane, 4-isopropyldibenzoylmethane, 3-benzylidenecamphor, 3- (4-methylbenzylidene) camphor, titanium dioxide, zinc, silica, iron oxide, and mixture thereof. Still other useful sunscreens are those described in U.S. Patent No. 4,937,370 to Sabatelli, issued June 26, 1990; and United States Patent
No. 4,999,186, of Sabatelli et al., issued March 12, 1991; these two references are incorporated herein by reference in their entirety.
Especially preferred examples of these sunscreens include those selected from the group consisting of 4-N, N-2 (-ethylhexyl) methylaminobenzoic acid ester of 2,4-dihydroxybenzophenone, 4-N, N- (2-ethylhexyl) ester methylaminobenzoic acid with 4-hydroxydibenzoylmethane, 4-N, N- (2-ethylhexyl) -methylaminobenzoic acid ester of 2-hydroxy-4- (2-hydroxyethoxy) benzophenone, 4-N, N- (2-ethylhexyl) ester 4- (2-hydroxyethoxy) dibenzoylmethane-methylaminobenzoic acid, and mixtures thereof: Exact quantities of sunscreens that can be used will vary depending on the chosen sunscreen and the desired sun protection factor (SPF) that will be achieved. FPS is a commonly used photoprotection measure of a sunscreen against erythema. See Federal Register Vol. 43, No. 166, pp. 38206-38269, August 25,1978, which is incorporated herein by reference in its entirety. Non-limiting examples of preferred active ingredients useful herein include those selected from the group consisting of salicylic acid, benzoyl peroxide, niacinamide, cis-retinoic acid, trans-retinoic acid, retinol, retinylpalmitate, phytic acid, N-acetyl- cysteine, acelaic acid, lipoic acid, resorcinol, lactic acid, glycolic acid, and ibuprofen, naproxen, hydrocortisone, phenoxyethanol, phenoxypropanol, phenoxypropanol, 2,4,4, -trichloro-2'-hydroxydiphenyl ether, 3,4,4 '-trichlorocarbapilide, 2-ethylhexyl p-acid
methoxycinnamic, oxybenzone, 2-phenolbenz? m? dozole-5-sulphonic acid, dihydroxyacetone and mixtures thereof.
CATIONIC TENSIOACTIVE AGENTS
The products of the present invention may optionally include one or more cationic surfactants, provided that these materials are selected so as not to interfere with the total foaming characteristics of the required foaming surfactants. Non-limiting examples of cationic surfactants useful herein are described in McCutcheon's, Deteraents v Emulsifiers. North American edition (1986), published by Publishing Corporation; and McCutcheon's, Funtional Material. North American Edition (1992); which are incorporated herein by reference in their entirety. Non-limiting examples of cationic surfactants useful herein include cationic alkylammonium salts having the formula: wherein i is selected from an alkyl group having about 12 about 18 carbon atoms or aromatic, aryl or alkaryl groups, which they have about 12 about 18 carbon atoms; R2, R3 and R4 are independently selected from hydrogen, an alkyl group having from about 1 to about 18 carbon atoms, or aromatic, aryl or alkaryl groups having
about 12 about 18 carbon atoms; and X is a selected anion of chloride, bromide, iodide, acetate, phosphate, nitrate, sulfate, methyl sulfate, ethyl sulfate, ethoxylate, lactate, citrate, glycolate and mixtures thereof. Additionally, the alkyl groups may also contain ether linkages, or substituents of the hydroxyamino group (for example, the alkyl groups may contain portions of polyethylene glycol and prolipropylene glycol). More preferably, R-i is an alkyl group having from about 12 to about 18 carbon atoms; R2 is selected from H or an alkyl group having from about 1 to about 18 carbon atoms; R3 and R4 are independently selected from H an alkyl group having about 1 about 3 carbon atoms; and X is as described in the previous paragraph. More preferably still R - is an alkyl group having about 12 about 18 carbon atoms; R2, R3 and R are selected from H or an alkyl group having from about 1 to about 3 carbon atoms; X is as described above. Alternatively, other useful cationic surfactants include aminoamides, wherein the above structure Ri is alternatively R5cO- (CH2) n-, wherein 5 is an alkyl group having about 12 about 22 carbon atoms, and n is an about 2 about 6, more preferably about 2 about 4, and more preferably about 2 about 3. Non-limiting examples of these cationic emulsifiers include chloride
phosphate stearamidopropyl PG-dimonium, stearamidopropylethyldimonethoesulfate, stearamidopropyl dimethyl (myristylacetate) ammonium chloride, stearamidopropyldemityl-cetearylmonium ethoxylate, stearamidopropyl dimethyl ammonium chloride, stearamidopropyl dimethyl ammonium lactate and mixtures thereof. Non-limiting examples of cationic surfactants of quaternary ammonium salts include those selected from the group consisting of cetialammonium chloride, cetylammonium bromide, lauryl ammonium chloride, laurylammonium bromide, stearylammonium chloride, stearylammonium bromide, cetyl dimethyl ammonium chloride, cetildimetilamonio of laurildimetilamonlo chloride, bromide lauryl, of stearyldimethylammonium chloride, bromide stearyldimethylammonium of cetildimetilamonio chloride, bromide cetildimetilamopio of laupldimetilamonio chloride, bromide lauryl, stearyl chloride, bromide stearyltrimethylammonium lauryldimethylammonium chloride, estearildimetilcetildisebodimetilamonio chloride, dicetylammonium chloride, dicetyl ammonium bromide, dilaurammonium chloride, dilauryl ammonium bromide, disterearilamonium chloride, distearylammonium bromide, dicetylmethylammonium chloride, dicetylmethylammonium bromide, chloro of dilaurylmethylammonium, dilaurylmethyl ammonium bromide, distearylmethylammonium chloride, distearylmethylammonium chloride, distearylmethylammonium bromide and mixtures thereof. Quaternary ammonium salts
Additional features include that in the C12 to C22 alkylcarbon chain they are derived from a tallow fatty acid or a coconut fatty acid. The term
(tallow) refers to an alkyl group derived from tallow fatty acids (usually hydrogenated tallow fatty acids), which generally has mixtures of alkyl chains on the C16 to C18 scale. The thermal "coconut" refers to an alkyl group derived from a coconut fatty acid, which generally has mixtures of alkyl chains on the scale of C12 to C14. Examples of quaternary ammonium salts derived from these coconut and tallow sources include ditallowdimethylammonium chloride, ditallowdimethylammoniomethylsulfate, dl (tallowhydrogenated) dimethylammonium chloride, dl (tallowhydrogenated) dimethylammonioacetate, dibodipropylammonophosphate, ditallowdimethylammonitrate, di (cocoalkyl) dimethylammonium chloride, bromide di (cocoalkyl) dimethylammonium, tallowammonium chloride, cocoammonium chloride, stearamidopropyl PG dimonium chloride-phosphate, stearamidopropyl-dimonioethosulfate, stearamidopropylmethyl (myristylacetate) ammonium chloride, stereoamidopropylmethylketethylammonioethoxylate, stearamidopropyl dimethyl ammonium chloride, stereoamidopropyldimethylammoniolactate and mixtures thereof. Preferred cationic surfactants useful herein include those selected from the group consisting of dilaupldimethylammonium chloride, chlorurodistearyldimethylammonium, dimyristylammonium chloride,
dipalmityldimethylammonium, disteapldimethylammonium chloride and mixtures thereof.
WATER SOLUBLE CONDITIONING AGENTS
The present invention can optionally also include water soluble conditioners. Non-limiting examples of water-conditioning agents useful as water-soluble conditioning agents include those selected from the group consisting of polyhydric alcohols, polypropylene glycols, polyethylene glycols, ureas, pyrrolidonecarboxylic acids, ethoxylated and / or C3-C6 propoxylated triols and triols, C2 carboxylic acids -C6 alphahydroxy, ethoxylated and / or propoxylated sugars, polyacrylic acid copolymers, sugars having up to about 12 carbon atoms, sugar alcohols having up to 12 carbon atoms and mixtures thereof. Specific examples of useful water-soluble conditioning agents include materials such as guanidine; glycolic acid, and glycolate salts (eg, ammonium and quaternary alkylammonium); lactic acid and lactate salts (for example, ammonium and alkylammonium-quaternary); sucrose, fructose, glucose, eructrssa, erythritol, sorbitol, mannitol, glycerol, hexantriol, propylene glycol, butylene glycol, hexylene glycol and the like; polyethylene glycols such as PEG-3, PEG-3, PEG-30 PEG-50, polypropylene glycols such as PPG-9, PPG-12, PPG-15, PPG-17, PPG-20, PPG-26, PPG.30, PPG-34; alkoxylated glucose; hyaluronic acid and
mixtures thereof. Matepales also useful are aloe vera in any of its varieties of forms (for example, aloe vera gel), chitin, sodium polyacrylate grafted in starch such as Sanwet (RTM) IM-1000, IM-1500- and IM-2500 (available from Celanese Superabsorbent Matepals, Portsmouth, VA); lactamide monoethanolamine; acetamide monoethanolamine; and mixtures thereof. Propoxylated glycerols are also useful as described in propoxylated glycerols described in US Pat. No. 4,976,953, to Orr et al., Issued December 11, 1990, which is hereby incorporated by reference in its entirety.
OTHER OPTIONAL INGREDIENTS
The compositions of the present invention may include a wide variety of other optional components. These additional components must be pharmaceutically acceptable. CTFA Cosmetic Ingredient Hnadbook, 2nd. Edition, 1992, which is incorporated by reference herein in its entirety, discloses a wide variety of non-limiting cosmetic and pharmaceutical ingredients commonly used in the skin care industry, which are suitable for use in the compositions of the present invention. Non-limiting examples of classes of ingredients are described on page 537 of this reference. Examples of these and other functional classes include: abrasives, absorbers, anti-caking agents, antioxidants, vitamins, binders, biological additives, pH-improving agents, bulking agents , chelating agents, additives
chemicals, colorants, astringents with cosmetics, cosmetics biocides, denaturants, drug astringents, external analgesics, film formers, fragrance components, humectants, opacifying agents, pH adjusters, preservatives, propellants, reducing agents, skin bleaching agents, and sunscreen agents. Also useful here are the aesthetic components such as fragrances, pigments, dyes, essential oils, skin sensitizers, astringents, skin softening agents and skin healing agents.
MANUFACTURING METHODS
The single-use disposable personal care cleaning and conditioning products of the present invention are manufactured by adding or impregnating separately or simultaneously in a water-insoluble substrate a foaming surfactant and a conditioning agent, wherein said resulting product is substantially dry. . By "separately" it is understood that surfactants and conditioning agents can be added sequentially, in any order without being combined first. By "simultaneously" it is understood that surfactants and conditioning agents can be added at the same time, with or without first being combined. For example, the foaming surfactants may first be added to or impregnated in the water insoluble substrate followed by the softening conditioning agents. Alternatively,
the foaming surfactants and conditioning agents can be added or impregnated in the water insoluble substrate at the same time. Alternatively, the foaming surfactants and conditioning agents can be combined before being added or impregnated in the water insoluble substrate. The surfactant, conditioning agents and any optional ingredients may be added to or impregnated into the water insoluble substrate by any means known to those skilled in the art: for example, by spraying, laser printing, splashing, dipping, soaking, coating. When water or moisture is used or is presented in the manufacturing process, the resulting treated substrate is subsequently dried so that it is substantially free of water. The treated substrate can be dried by any means known to those skilled in the art. Non-limiting examples of known drying media include the use of convection ovens, radiant heat sources, microwave ovens, forced air ovens and heated cylinders or cans. Drying also includes air drying without the addition of heat energy, unlike that present in the environment. Also, a combination of various drying methods can be used.
METHODS OF CLEANSING AND CONDITIONING HAIR OR SKIN
The present invention also relates to a method for cleaning and conditioning the skin or hair with a personal cleansing product of the present invention. These methods include the steps of moistening with water a substantially dry, disposable, and unique personal use cleaning product that includes a water-insoluble substrate, a foaming surfactant, and a conditioning component and the skin or hair comes into contact with said wet product. In other embodiments, the present invention is also useful for delivering various active ingredients to the skin or hair. The products of the present invention are substantially dry and are intended to be moistened with water before use. The product is moistened by immersion in water or by placing it under a stream of water. The foam is generated from the product by mechanical agitation and / or deforming the product, either before or during the contact of the product with the skin or hair. The resulting foam is useful for cleaning and conditioning the skin or hair. During the procedure of cleaning and subsequent rinsing with water, conditioning agents and active ingredients are deposited on the skin or hair. The deposition of conditioning agents and active ingredients is increased by physical contact of the skin or hair substrate.
DEPOSITION OF THE COMPONENT ACONCIONADOR AND ANY ACTIVE INGREDIENT IN THE SKIN OR HAIR
The compositions of the present invention are useful for depositing the conditioning components of the present invention to the skin or hair. In other embodiments where an active ingredient is present, the compositions are also useful for depositing the active ingredient on the skin or hair. The compositions of the present invention preferably deposit an amount greater than about 2.5 micrograms / cm2, more preferably greater than about 5 micrograms / cm2, more preferably greater than about 10 micrograms / cm2 and more preferably even greater than about 25 micrograms / cm2 of the component conditioner to the skin or hair during the use of the product. The present invention also relates to a method for depositing an amount greater than about 2.5 micrograms / cm 2, preferably greater than about 5 micrograms / cm 2 more preferably greater than about 10 micrograms / cm 2, and more preferably even greater than about 25 micrograms / cm 2 of the skin or hair surface conditioning agent. The amount of the conditioning component deposited on the skin or hair can be measured by a variety of standard analytical techniques well known in the chemistry of those skilled in the art. Such methods include for example the removal of an area of skin or hair with
a suitable solvent followed by analysis by chromatography (for example, gas chromatography, liquid chromatography, super critical fluid chromatography, etc.), IR spectroscopy UV spectroscopy? IS, mass spectrometry, etc. Direct measurements can also be made on the skin or hair by techniques such as IR spectroscopy, UV VIS spectroscopy, opacity measurement, fluorescence spectroscopy, ESCA spectroscopy and the like. In a typical method for measuring deposition, a product of the present invention is moistened with water, pressed and agitated to generate a foam. The product is subsequently rubbed for approximately 15 seconds at one site, approximately about 25 cm 2 to about 300 cm 2, preferably about 50 cm 2 about 100 cm 2 on the skin or head that has been marked using an appropriate indelible marker. The site is subsequently rinsed for approximately 10 seconds and subsequently allowed to air dry for approximately 10 minutes. Subsequently, the site is extracted and the extracts analyzed or analyzed directly using any technique such as those described above.
EXAMPLES
The following examples further describe and demonstrate embodiments within the scope of the present invention. In the following
examples, all ingredients are listed at an active level. The examples are given only for purposes of illustration and are not intended as a limit of the present invention, since many variations thereof are possible without departing from the essence and scope of the invention. The ingredients are identified by chemical or name
CTFA.
EXAMPLES 1-4
A personal care cleaning and conditioning product is prepared as follows:
Ingredients% by weight Example 1 Example 2 Example 3 Example 4
Phase A Water CBP 100 CBP 100 CBP 100 CBP 100
Glycerin 10.00 10.00 10.00 10.00
Disodium lauroamphodiacetate and sodium tridecetsulfate 4.00 4.00 - - Lauroamphoacetate - - 2.40 2.40 sodium
Lauroyl sarcosinate 4.00 4.00 - - sodium Ammonium Laureth Sulfate - - 4.20 4.20
Ammonium lauryl sulfate - - 1.40 1.40
Policuartemo-10 0.25 0.25 0.25 0.25
Disodium ETDA 0.10 0.10 0.10 0.10
Phase B Fatty acid carbonate of sucrose ester 3.00 3.00 3.00 3.00
Petrolato - 1.50 - -
Cetildimeticop - - - 2.00
Phase C Butylene glycol 2.00 2.00 2.00 2.00
Hidantoin DMDM and microwaves.
INSOLUBLE SUBSTRATE IN WATER A non-woven, non-woven substrate containing a basis weight of approximately 387 cm2 including 50% rayon and 50% polyester approximately 15 cm by 19 cm and a thickness of approximately 508
In a suitable container, the ingredients of Phase A are mixed at room temperature to form a dispersion and heat while stirring at 65 °. The ingredients of Phase B are mixed in a separate suitable container and heated to 65 ° C. Once the temperatures are the same, the ingredients of Phase B are mixed in the container containing the ingredients of Phase A and then cooled to 45 ° C. The ingredients of Phase C are then mixed together in a separate container at room temperature. Subsequently, the mixture of Phase C is added to the container containing the combination of Phases A and B at room temperature. 1.5 grams of the resulting solution is sprayed on each substrate. Alternatively, the substrate can be immersed in the resulting solution. The subsequently treated substrate is dried in a homo for constant weight. Alternatively, the treated substrate is dried in a convection oven at 45 ° C for constant weight. The resulting cleaning composition is used when moistening it with water and is useful for cleaning the skin or hair and for depositing the conditioning agent on the skin or hair. In alternative manufacturing processes, the foaming surfactants, conditioning agents and optional ingredients may be added or impregnated separately or simultaneously in the water insoluble substrate by spraying, laser printing, splashing, dipping or coating.
In alternative embodiments, other substrates such as woven substrates, hydroentangled substrates, natural sponges, synthetic sponges or baskets of polymeric networks.
EXAMPLES 5-8
A personal care cleaning and conditioning product is prepared as follows: Ingredients% by weight - Example 5 Example 6 Example 7
Example 8 Phase A Water CBP 100 CBP 100 CBP 100
CBP 100 Glycerin 10.00 10.00 10.00 10.00
Pantenol 0.50 - 0.50 0.50
Sodium lauroamphoxide 2.40 2.40 2.40 2.40
Ammonium lauryl sulfate 1.40 1.40 1.40 1.40
Policuarternio-10 0.25 0.25 0.25 0.25
Disodium EDTA 0.10 0.10 0.10 0.10
Phase B Fatty acid algodonate
sucrose ester 3.00 3.00 3.00 3.00
Petrolato - - - 0.50
Cetildimethicone - - -
0. 50 Cetiiricinoleate - 2.00 2.00 1.00
Phase C Butylene glycol 2.00 2.00 2.00
2. 00 Hidantoina DMDM and lodopropinil Carbamate.
0. twenty
SUBSTRATE INSQLUBLE IN WATER A hydrophobic nonwoven substrate containing a basis weight of approximately 387 cm2 including 50% rayon and 50% polyester approximately 15 cm by 19 cm and a thickness of approximately 508 microns. In a suitable container, the ingredients of Phase A are mixed at room temperature to form a dispersion and heat while stirring at 65 °. The ingredients of Phase B are mixed in a separate suitable container and heated to 65 ° C. Once the temperatures are the same, the ingredients of Phase B are mixed in the
container containing the ingredients of Phase A and subsequently cooled to 45 ° C. The ingredients of Phase C are then mixed together in a separate container at room temperature. Subsequently, the mixture of Phase C is added to the container containing the combination of Phases A and B at room temperature. 1.5 grams of the resulting solution is sprayed on each substrate. Alternatively, the substrate can be immersed in the resulting solution. The subsequently treated substrate is dried in a homo for constant weight. Alternatively, the treated substrate is dried in a convection oven at 45 ° C for constant weight. The resulting cleaning composition is used when moistening it with water and is useful for cleaning the skin or hair and for depositing the conditioning agent on the skin or hair. In alternative manufacturing processes, the foaming surfactants, conditioning agents and optional ingredients may be added or impregnated separately or simultaneously in the water insoluble substrate by spraying, laser printing, splashing, dipping or coating. In alternative embodiments, other substrates such as woven substrates, hydroentangled substrates, natural sponges, synthetic sponges or baskets of polymeric networks.
EXAMPLES 9-12
Ingredients% by weight Example 9 Example 10 Example 11 Example 12 Phase A Water CBP 100 CBP 100 CBP 100 CBP
100 Disodium and tridecetsulfonated sodium lauroamphodiacetate 4.00 4.00 - - Sodium lauroamphodiacetate - - 2.40
2. 40 Laurilsarcosinate sodium 4.00 4.00 - -
Ammonium Laureth Sulfate - - 4.20 4.20 Ammonium Laurysulfate - - 1.40
1. 40 Disodium EDTA 0.10 0.10 0.10
0. 10
Phase B Fatty acid cotonate of sucrose ester 3.00 3.00 3.00 3.00
Petrolato - 1.50 - -
Cetildimeticon - - -
2. 00
Phase C Hidantoin DMDM and lodopropinil Carbamate.
0. 20 INSOLUBLE SUBSTRATE IN WATER
A hydro-apertured nonwoven substrate containing a basis weight of about 387 cm 2 including 50% rayon and 50% polyester approximately 15 cm by 19 cm and a thickness of approximately 508 microns. In a suitable container, the ingredients of Phase A are mixed at room temperature to form a dispersion and heat while stirring at 65 °. The ingredients of Phase B are mixed in a separate suitable container and plated at 65 ° C. Once the temperatures are the same, the ingredients of Phase B are mixed in the container containing the ingredients of Phase A and then cooled to 45 ° C. The ingredients of Phase C are then mixed together in a separate container at room temperature. Subsequently, the mixture of Phase C is added in the container containing the combination
of Phases A and B at room temperature. 1.5 grams of the resulting solution is sprayed on each substrate. Alternatively, the substrate can be immersed in the resulting solution. The subsequently treated substrate is dried in a homo for constant weight. Alternatively, the treated substrate is dried in a convection oven at 45 ° C for constant weight. The resulting cleaning composition is used when moistening it with water and is useful for cleaning the skin or hair and for depositing the conditioning agent on the skin or hair. In alternative manufacturing processes, the foaming surfactants, conditioning agents and optional ingredients can be added or impregnated separately or simultaneously in the water-insoluble substrate by spraying, laser printing, splashing, immersion or coating. In alternative embodiments, other substrates such as woven substrates, hydroentangled substrates, natural sponges, synthetic sponges or baskets of polymeric networks.
EXAMPLES 13-16
Ingredients% by weight Example 13 Example 14 Example 15 Example 16 Phase A Water CBP 100 CBP 100 CBP 100 CBP
100 Sodium lauroamphoate 2.40 2.40 2.40 2.40 Ammonium Laureth Sulfate 4.20 4.20 4.20 4.20
Ammonium lauryl-amidate 1.40 1.40 1.40 1.40
Disodium EDTA 0.10 0.10 0.10 0.10
Phase B Fatty acid cotonate of sucrose ester 3.00 3.00 3.00 3.00
Petrolatum - 0.50 1.0 Cetildimeticon - 1.50 - 1.00
Cetilricinoleate 2.00 0.50 1.00 1.00
Phase C Hydantoin DMDM and lodopropinil
Carbamate.
0. twenty
SUBSTRATE INSOLUBLE IN WATER
A hydrophobic nonwoven substrate containing a basis weight of about 387 cm 2 including 50% rayon and 50% polyester approximately 15 cm by 19 cm and a thickness of approximately 508 microns. In a suitable container, the ingredients of Phase A are mixed at room temperature to form a dispersion and heat while stirring at 65 °. The ingredients of Phase B are mixed in a separate suitable container and heated to 65 ° C. Once the temperatures are the same, the ingredients of Phase B are mixed in the container containing the ingredients of Phase A and then cooled to 45 ° C. The ingredients of Phase C are then mixed together in a separate container at room temperature. Subsequently, the mixture of Phase C is added to the container containing the combination of Phases A and B at room temperature. 1.5 grams of the resulting solution is sprayed on each substrate. Alternatively, the substrate can be immersed in the resulting solution. The subsequently treated substrate is dried in a homo for constant weight. Alternatively, the treated substrate is dried in a convection oven at 45 ° C for constant weight.
The resulting cleaning composition is used when moistening it with water and is useful for cleaning the skin or hair and for depositing the conditioning agent on the skin or hair. In alternative manufacturing process, the foaming surfactants, conditioning agents and optional ingredients can be added or impregnated separately or simultaneously in the water-insoluble substrate by spraying, laser printing, splashing, dipping or coating. In alternative embodiments, other substrates such as woven substrates, hydroentangled substrates, natural sponges, synthetic sponges or baskets of polymeric networks.
Claims (22)
1. - A disposable personal care cleaning and conditioning product for single use that includes: (A) a water-insoluble substrate, (B) a foaming surfactant, and (C) an oil-soluble conditioning agent, further characterized in that said product The cleaning agent deposits an amount greater than about 2.5 μg / cm2 of said oil-soluble conditioning agent to the surface of the skin or hair and because said product is substantially dry.
2. A product according to claim 1, further characterized in that said foaming surfactant includes from about 0.5% to about 12.5% by weight of said water-insoluble substrate and said oil-soluble conditioning agent including about 1% to about 99% by weight of said water-insoluble substrate.
3. A product according to claim 1, further characterized in that the weight ratio of the foaming surfactant to the oil-soluble conditioning agent is less than about 20: 1.
4. A product according to claim 1, further characterized in that said water-insoluble substrate includes one or more materials selected from the group consisting of silks, keratins, celluloses, acetates, acrylics, cellulose esters, modacrylics, polyamides, polyesters, polyolefins, polyvinyl alcohols and mixtures thereof.
5. A product according to claim 4, further characterized in that said water insoluble substrate includes one or more materials selected from the group consisting of wood pulp, cotton, hemp, jute, linen, acrylics, nylons, polyesters, polypropylenes , polyethylenes, polyvinylacetates, polyurethanes, rayon, and mixtures thereof.
6. - A product according to claim 5, further characterized in that said water-insoluble substrate is selected from the group consisting of non-woven substrates, woven substrates, hydroentangled substrates, natural sponges, synthetic sponges, meshes of polymeric networks, formed films and blends thereof.
7. A product according to claim 5, further characterized in that said water-insoluble substrate includes a non-woven fiber sheet selected from the group consisting of rayon fibers, cellulose fibers, polyester fibers and mixtures thereof.
8. A product according to claim 7, further characterized in that said water-insoluble substrate includes two or more sheets of fibers which in turn each have different textures.
9. A product according to claim 1, further characterized in that said foaming surfactant is selected from the group consisting of foaming surfactants ammonia, nonionic foaming surfactants, amphoteric foaming surfactants and mixtures thereof.
10. A product according to claim 9, further characterized in that said anionic foaming surfactant is selected from the group consisting of sarcosinates, sulfates, isethionates, phosphates, taurates, and mixtures thereof; further characterized in that said nonionic foaming surfactant is selected from the group consisting of amine oxides, alkyl glucosides, alkyl polyglycosides, polyhydroxy fatty acid amides, alkoxylated fatty acid esters, sucrose esters and mixtures thereof; and further characterized in that said amphoteric foaming surfactant is selected from the group consisting of betaines, sultaines, hydroxysultaines, alkyliminoacetates, alkanoates, aminoalkanoates, and mixtures thereof.
11. A product according to claim 10, further characterized in that said anionic foaming surfactant is selected from the group consisting of ammonium lauroyl sarcosinate, sodium tridecetsulfate, sodium lauroyl sarcosinate, ammonium laureth sulfate, sodium laureth sulfate, ammonium lauryl sulfate. , sodium laurisulfate, ammonium cocoyl isethionate, sodium cocoyl isethionate, sodium lauroyl isethionate, sodium cetiisulfate, and mixtures thereof; further characterized in that said nonionic foaming surfactant is selected from the group consisting of lauramine oxide, cocoamine oxide, decyl polyglucose, lauryl polyglucose, C12-14 glucose amide, cocoate Sucrose, sucrose laurate, and mixtures thereof; and characterized f, further in that said amphoteric foaming surfactant is selected from the group consisting of disodium lauroamphodiacetate, sodium lauroamphoacetate, cetyl dimethylbetaine, cocoamidopropylbetaine, 5 cocoamidopropylhydroxysultaine, and mixtures thereof.
12. A product according to claim 1, further characterized in that said oil-soluble conditioning agent is selected from 1 or more oil-soluble conditioning agents whereby the heavy arithmetic mean solubility parameter of said agent 10 oil-soluble conditioner is less than or equal to 10.5.
13. A product according to claim 12, further characterized in that said oil-soluble conditioning agent is selected from the group consisting of fatty acid esters, polyol polyesters, glycerin monoesters, gylcerin diesters, triesters 15 glycerin, epidermal and sebaceous hydrocarbons, lanolin, mineral oil, silicone oil, vegetable oil, vegetable oil adduct, petrolatum, non-ionic polymers and mixtures thereof.
14. A product according to claim 1, further characterized in that said cleaning product also includes a The safe and effective amount of one or more active ingredients selected from the group consisting of active ingredients anti-acne, anti-wrinkle and antiatrophy of the skin, non-steroidal anti-inflammatory active ingredients, topical anesthetics, artificial tanning agents and accelerators, agents antimicrobials and antifungals, active ingredients of sunscreen, antioxidants and mixtures thereof.
15. A product according to claim 14, further characterized in that said active ingredient is selected from the group consisting of salicylic acid, niacinamide, benzoyl peroxide, cis-retinoic acid, trans-retinoic acid, retinol, retinyl palmitate, phytic acid , N-acetyl L-cysteine, azelaic acid, lipoic acid, resorcinol, lactic acid, glycolic acid, buprofen, naproxen, hydrocortlsone, phenoxyethanol, phenoxypropanol, phenoxyisopropanol, ether 2,4,4 ', - trichloro-2'-hydroxy diphenylic acid, 3,4,4'-trichlorocarbanilide, 2-ethylhexyl p-methoxycinnamic acid, oxybenzone, 2-phenylbenzimidizole-5-sulfonic acid, dihydroxyacetone and mixtures thereof.
16. A single-use disposable personal care conditioning cleaning product that includes: (A) a water-insoluble substrate, and (B) a cleaning and conditioning composition that includes: (i) a foaming surfactant and ( ii) an oil-soluble conditioning agent, further characterized in that said foaming surfactant and said oil-soluble conditioning agent are added or impregnated separately or simultaneously to the water-insoluble substrate and further characterized in that the weight ratio of the foaming surfactant to the agent oil-soluble conditioner is less than about 20: 1, further characterized in that said cleaning product deposits an amount greater than about 2.5 μg / cm2 of said agent »Oil-soluble conditioner to the surface of the skin or hair and also characterized in that said product is substantially dry.
17. A product according to claim 16, further characterized in that said foaming surfactant includes 5 from about 1% to about 75% by weight of said cleaning and conditioning composition and said oil-soluble conditioning agent includes from about 5% to about 99% by weight of said cleaning and conditioning composition.
18. A method for manufacturing a personal care disposable cleaning and conditioning product for single use that includes the step of adding or impregnating separately or simultaneously in a water-insoluble substrate (A) a foaming surfactant and (B) a oil-soluble conditioning agent, further characterized in that the weight ratio of the foaming surfactant to the conditioning agent 15 soluble in oil is less than about 20: 1, further characterized in that said cleaning product deposits an amount greater than about 2.5 μg / cm2 of said oil-soluble conditioning agent to the surface of the skin or hair and further characterized in that said product resulting is substantially dry.
19. A method for manufacturing a product according to claim 18, further characterized in that said foaming surfactant and said oil-soluble conditioner are combined together before being added or impregnated in said water-insoluble substrate. t 20.- A method for manufacturing a product in accordance with i. { claim 18, further characterized in that the foaming surfactant and the oil-soluble conditioning agent are added or impregnated separately or simultaneously in a water insoluble substrate 5 by spraying, laser printing, splashing, dipping or coating. 21. A method for depositing an amount greater than about 2.5 μg / cm2 of said oil-soluble conditioning agent to the surface of the skin or hair using the product according to claim 1. 22.- A cleaning method and Conditioning the skin or hair with a personal cleansing product that includes the steps of: (A) moistening with water a unique disposable and dry personal cleansing product that includes: (i) a water-insoluble substrate, (i) ) a 15 foaming surfactant and (ii) an oil-soluble conditioning agent, further characterized in that the weight ratio of the foaming surfactant to the oil-soluble conditioning agent is less than about 20: 1, and (B) that the hair or skin come into contact with said wet product, further characterized in that said product The cleaning deposits an amount greater than about 2.5 μg / cm2 of said oil-soluble conditioning agent to the surface of the skin or hair.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08738194 | 1996-10-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA99003921A true MXPA99003921A (en) | 1999-10-14 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0946141B1 (en) | Cleansing products | |
EP0938291B1 (en) | Cleansing products | |
AU733192B2 (en) | Cleansing products | |
AU740839B2 (en) | Cleansing products with improved moisturization | |
CZ144499A3 (en) | Disposable ready personal cleansing and treating article, process of its preparation and use | |
AU5087898A (en) | Cleansing products | |
AU5150198A (en) | Cleansing products | |
MXPA99003921A (en) | Cleansing products | |
MXPA99003919A (en) | Cleansing products | |
MXPA99003916A (en) | Cleansing products | |
MXPA99003920A (en) | Cleansing products | |
MXPA99003922A (en) | Cleansing products | |
MXPA99010791A (en) | Cleansing products with improved moisturization | |
MXPA99010793A (en) | Cleansing products with improved moisturization |